https://www.pharmaceutical-technology.com/data-insights/tumor-necrosis-factor-ligand-superfamily-member-11-drugs-in-development/ 2024-10-01T03:49:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/broad-substrate-specificity-atp-binding-cassette-transporter-abcg2-drugs-in-development/ 2024-10-01T02:40:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ephrin-type-a-receptor-2-drugs-in-development/ 2024-10-01T02:52:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rac-beta-serine-threonine-protein-kinase-drugs-in-development/ 2024-10-01T03:24:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/caspase-1-interleukin-1-beta-convertase-or-interleukin-1-beta-converting-enzyme-or-p45-or-casp1-or-ec-3-4-22-36-drugs-in-development/ 2024-08-30T06:51:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/casein-kinase-2-drugs-in-development/ 2024-10-01T02:43:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-22-receptor-drugs-in-development/ 2024-10-01T03:02:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pyruvate-kinase-pklr-drugs-in-development/ 2024-10-01T03:24:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mucolipin-1-drugs-in-development/ 2024-10-01T03:08:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/serum-albumin-drugs-in-development/ 2024-10-01T03:29:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/solute-carrier-family-12-member-2-basolateral-na-k-cl-symporter-or-bumetanide-sensitive-sodium-potassium-chloride-cotransporter-1-or-slc12a2-or-nkcc1-drugs-in-development/ 2024-08-30T06:49:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vascular-endothelial-growth-factor-a-drugs-in-development/ 2024-10-01T03:52:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-8-drugs-in-development/ 2024-10-01T03:03:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ornithine-decarboxylase-drugs-in-development/ 2024-10-01T03:17:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/3-oxo-5-alpha-steroid-4-dehydrogenase-2-drugs-in-development/ 2024-10-01T02:26:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sphingosine-1-phosphate-receptor-1-drugs-in-development/ 2024-10-01T03:45:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/c-x-c-chemokine-receptor-type-3-drugs-in-development/ 2024-10-01T02:47:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ccaat-enhancer-binding-protein-drugs-in-development/ 2024-10-01T02:44:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tumor-necrosis-factor-ligand-superfamily-member-15-drugs-in-development/ 2024-10-01T03:49:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/signal-transducer-and-activator-of-transcription-6-drugs-in-development/ 2024-10-01T03:29:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/methionine-aminopeptidase-drugs-in-development/ 2024-10-01T03:06:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bifunctional-epoxide-hydrolase-2-drugs-in-development/ 2024-10-01T02:42:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/farnesyl-pyrophosphate-synthase-drugs-in-development/ 2024-10-01T02:52:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nicotinamide-n-methyltransferase-drugs-in-development/ 2024-10-01T03:15:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inosine-monophosphate-dehydrogenase-drugs-in-development/ 2024-10-01T02:59:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/thyroid-hormone-receptor-alpha-nuclear-receptor-subfamily-1-group-a-member-1-or-v-erba-related-protein-7-or-c-erba-1-or-c-erba-alpha-or-ear7-or-thra-drugs-in-development/ 2024-08-30T06:44:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/n-formyl-peptide-receptor-2-drugs-in-development/ 2024-10-01T03:15:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/p2y-purinoceptor-12-drugs-in-development/ 2024-10-01T03:18:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/corticotropin-releasing-factor-receptor-1-drugs-in-development/ 2024-10-01T02:47:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cxxc-type-zinc-finger-protein-5-putative-mapk-activating-protein-pm08-or-putative-nf-kappa-b-activating-protein-102-or-retinoid-inducible-nuclear-factor-or-cxxc5-drugs-in-development/ 2024-08-30T06:24:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/human-sars-coronavirus-2-rna-dependent-rna-polymerase-drugs-in-development/ 2024-10-01T02:58:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/triggering-receptor-expressed-on-myeloid-cells-1-drugs-in-development/ 2024-10-01T03:49:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/double-stranded-rna-specific-adenosine-deaminase-drugs-in-development/ 2024-10-01T02:50:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/b-cell-lymphoma-leukemia-11a-drugs-in-development/ 2024-10-01T02:41:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nkg2-d-type-ii-integral-membrane-protein-drugs-in-development/ 2024-10-01T03:16:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ornithine-carbamoyltransferase-mitochondrial-drugs-in-development/ 2024-10-01T03:17:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ribosomal-protein-s6-kinase-ii-drugs-in-development/ 2024-10-01T03:26:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nadph-oxidase-4-drugs-in-development/ 2024-10-01T03:15:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inactive-tyrosine-protein-kinase-transmembrane-receptor-ror1-drugs-in-development/ 2024-10-01T02:58:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/protein-mono-adp-ribosyltransferase-tiparp-drugs-in-development/ 2024-10-01T03:23:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/calpain-1-catalytic-subunit-calcium-activated-neutral-proteinase-1-or-calpain-mu-type-or-calpain-1-large-subunit-or-cell-proliferation-inducing-gene-30-protein-or-micromolar-calpain-or-capn1-or-ec-3-4/ 2024-08-30T06:21:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/transmembrane-protease-serine-2-drugs-in-development/ 2024-10-01T03:49:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sodium-channel-protein-type-10-subunit-alpha-drugs-in-development/ 2024-10-01T03:30:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tumor-necrosis-factor-ligand-superfamily-member-13b-drugs-in-development/ 2024-10-01T03:49:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-17f-drugs-in-development/ 2024-10-01T03:01:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/transthyretin-drugs-in-development/ 2024-10-01T03:49:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/squalene-monooxygenase-drugs-in-development/ 2024-10-01T03:45:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ileal-sodium-bile-acid-cotransporter-drugs-in-development/ 2024-10-01T02:58:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/programmed-cell-death-1-ligand-2-drugs-in-development/ 2024-10-01T03:21:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/receptor-activity-modifying-protein-2-drugs-in-development/ 2024-10-01T03:25:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/camp-specific-3-5-cyclic-phosphodiesterase-4b-drugs-in-development/ 2024-10-01T02:43:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/raf-proto-oncogene-serine-threonine-protein-kinase-drugs-in-development/ 2024-10-01T03:25:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/receptor-activity-modifying-protein-1-drugs-in-development/ 2024-10-01T03:25:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/t-cell-surface-glycoprotein-cd3-epsilon-chain-drugs-in-development/ 2024-10-01T03:46:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cystine-glutamate-transporter-drugs-in-development/ 2024-10-01T02:48:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tyrosine-protein-kinase-jak2-drugs-in-development/ 2024-10-01T03:51:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tyrosine-protein-kinase-jak3-drugs-in-development/ 2024-10-01T03:51:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rac-alpha-serine-threonine-protein-kinase-drugs-in-development/ 2024-10-01T03:24:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/retinoid-isomerohydrolase-drugs-in-development/ 2024-10-01T03:26:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gamma-aminobutyric-acid-receptor-subunit-alpha-1-drugs-in-development/ 2024-10-01T02:54:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/caspase-9-drugs-in-development/ 2024-10-01T02:44:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-11-receptor-drugs-in-development/ 2024-10-01T03:01:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-13-receptor-drugs-in-development/ 2024-10-01T03:01:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/leukocyte-immunoglobulin-like-receptor-subfamily-b-member-1-drugs-in-development/ 2024-10-01T03:04:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/leukocyte-immunoglobulin-like-receptor-subfamily-b-member-4-drugs-in-development/ 2024-10-01T03:04:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/polyunsaturated-fatty-acid-5-lipoxygenase-drugs-in-development/ 2024-10-01T02:31:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/synaptic-vesicle-glycoprotein-2a-drugs-in-development/ 2024-10-01T03:46:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/t-lymphocyte-activation-antigen-cd80-drugs-in-development/ 2024-10-01T03:46:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/c-c-chemokine-receptor-type-2-drugs-in-development/ 2024-10-01T02:44:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fatty-acid-synthase-drugs-in-development/ 2024-10-01T02:53:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ubiquitin-carboxyl-terminal-hydrolase-30-drugs-in-development/ 2024-10-01T03:52:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/thyroid-hormone-receptor-beta-drugs-in-development/ 2024-10-01T03:47:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/membrane-primary-amine-oxidase-drugs-in-development/ 2024-10-01T03:06:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/thrombopoietin-receptor-drugs-in-development/ 2024-10-01T03:47:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gastrin-cholecystokinin-type-b-receptor-drugs-in-development/ 2024-10-01T02:54:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xanthine-dehydrogenase-oxidase-drugs-in-development/ 2024-10-01T03:54:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glucose-dependent-insulinotropic-receptor-drugs-in-development/ 2024-10-01T02:55:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adiponectin-receptor-protein-1-drugs-in-development/ 2024-10-01T02:28:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cyclic-gmp-amp-synthase-drugs-in-development/ 2024-10-01T02:47:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/calcium-calmodulin-dependent-protein-kinase-type-ii-drugs-in-development/ 2024-10-01T02:43:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/antiviral-innate-immune-response-receptor-rig-i-drugs-in-development/ 2024-10-01T03:21:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/poly-adp-ribose-glycohydrolase-drugs-in-development/ 2024-10-01T03:20:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gtpase-nras-drugs-in-development/ 2024-10-01T02:56:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-1-receptor-like-2-drugs-in-development/ 2024-10-01T03:00:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/natural-cytotoxicity-triggering-receptor-1-drugs-in-development/ 2024-10-01T03:15:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/1-phosphatidylinositol-3-phosphate-5-kinase-drugs-in-development/ 2024-10-01T02:26:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/casein-kinase-i-isoform-alpha-drugs-in-development/ 2024-10-01T02:44:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/integrin-beta-6-drugs-in-development/ 2024-10-01T02:59:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tumor-necrosis-factor-receptor-superfamily-member-13c-drugs-in-development/ 2024-10-01T03:50:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/camp-and-camp-inhibited-cgmp-3-5-cyclic-phosphodiesterase-10a-drugs-in-development/ 2024-10-01T02:43:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nkg2-a-nkg2-b-type-ii-integral-membrane-protein-drugs-in-development/ 2024-10-01T03:16:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/intermediate-conductance-calcium-activated-potassium-channel-protein-4-drugs-in-development/ 2024-10-01T03:03:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-1-receptor-accessory-protein-drugs-in-development/ 2024-10-01T03:00:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cd27-antigen-drugs-in-development/ 2024-10-01T02:44:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dual-specificity-protein-kinase-ttk-drugs-in-development/ 2024-10-01T02:51:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/beta-galactosidase-drugs-in-development/ 2024-10-01T02:42:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/melatonin-receptor-type-1b-drugs-in-development/ 2024-10-01T03:06:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aldehyde-dehydrogenase-mitochondrial-drugs-in-development/ 2024-10-01T02:28:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/atrial-natriuretic-peptide-receptor-2-drugs-in-development/ 2024-10-01T02:40:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aurora-kinase-b-drugs-in-development/ 2024-10-01T02:41:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tyrosine-protein-kinase-abl1-drugs-in-development/ 2024-10-01T03:50:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/low-affinity-immunoglobulin-gamma-fc-region-receptor-iii-a-drugs-in-development/ 2024-10-01T03:04:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/thyrotropin-receptor-drugs-in-development/ 2024-10-01T03:47:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/progranulin-drugs-in-development/ 2024-10-01T03:21:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-18-receptor-1-drugs-in-development/ 2024-10-01T03:02:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/advanced-glycosylation-end-product-specific-receptor-drugs-in-development/ 2024-10-01T02:28:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/phosphatidylinositol-4-5-bisphosphate-3-kinase-catalytic-subunit-beta-isoform-drugs-in-development/ 2024-10-01T03:19:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-5-drugs-in-development/ 2024-10-01T03:02:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/complement-factor-h-drugs-in-development/ 2024-10-01T02:46:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/corticosteroid-11-beta-dehydrogenase-isozyme-1-drugs-in-development/ 2024-10-01T02:46:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fidgetin-like-protein-2-drugs-in-development/ 2024-10-01T03:24:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/beta-3-adrenergic-receptor-drugs-in-development/ 2024-10-01T02:41:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/c-x-c-chemokine-receptor-type-1-drugs-in-development/ 2024-10-01T02:47:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/membrane-associated-progesterone-receptor-component-1-drugs-in-development/ 2024-10-01T03:06:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neuropilin-1-drugs-in-development/ 2024-10-01T03:15:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/atp-dependent-translocase-abcb1-drugs-in-development/ 2024-10-01T03:08:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tumor-necrosis-factor-ligand-superfamily-member-4-drugs-in-development/ 2024-10-01T03:49:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/s-adenosylmethionine-synthase-isoform-type-2-drugs-in-development/ 2024-10-01T03:27:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nad-dependent-protein-deacetylase-sirtuin-1-drugs-in-development/ 2024-10-01T03:09:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dihydrofolate-reductase-drugs-in-development/ 2024-10-01T02:49:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neprilysin-drugs-in-development/ 2024-10-01T03:15:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/retinoic-acid-receptor-gamma-drugs-in-development/ 2024-10-01T03:26:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/11-beta-hydroxysteroid-dehydrogenase-drugs-in-development/ 2024-10-01T02:26:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/histamine-h3-receptor-drugs-in-development/ 2024-10-01T02:57:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/protein-phosphatase-2a-drugs-in-development/ 2024-10-01T03:23:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/guanine-nucleotide-exchange-c9orf72-drugs-in-development/ 2024-10-01T02:56:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eukaryotic-peptide-chain-release-factor-gtp-binding-subunit-erf3a-drugs-in-development/ 2024-10-01T02:52:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cyclin-dependent-kinase-19-drugs-in-development/ 2024-10-01T02:47:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ubiquitin-carboxyl-terminal-hydrolase-7-drugs-in-development/ 2024-10-01T03:52:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/respiratory-syncytial-virus-fusion-protein-drugs-in-development/ 2024-10-01T03:25:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/collagen-alpha-1-vii-chain-drugs-in-development/ 2024-10-01T02:46:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cyclin-dependent-kinase-12-drugs-in-development/ 2024-10-01T02:47:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nuclear-receptor-subfamily-2-group-f-member-6-drugs-in-development/ 2024-10-01T03:17:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/transcription-activator-brg1-drugs-in-development/ 2024-10-01T03:48:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/double-homeobox-protein-4-drugs-in-development/ 2024-10-01T02:50:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/coagulation-factor-xii-drugs-in-development/ 2024-10-01T02:46:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/monoglyceride-lipase-drugs-in-development/ 2024-10-01T03:07:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/calcium-release-activated-calcium-channel-protein-1-drugs-in-development/ 2024-10-01T02:43:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cytosolic-phospholipase-a2-drugs-in-development/ 2024-10-01T02:49:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/protein-o-glcnacase-drugs-in-development/ 2024-10-01T03:23:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/diacylglycerol-kinase-drugs-in-development/ 2024-10-01T02:49:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/epithelial-discoidin-domain-containing-receptor-1-drugs-in-development/ 2024-10-01T02:52:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cd276-antigen-drugs-in-development/ 2024-10-01T02:44:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aurora-kinase-a-drugs-in-development/ 2024-10-01T02:41:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/apolipoprotein-c-iii-drugs-in-development/ 2024-10-01T02:30:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cam-kinase-drugs-in-development/ 2024-10-01T02:43:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cyclin-dependent-kinase-1-drugs-in-development/ 2024-10-01T02:47:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/toll-like-receptor-4-drugs-in-development/ 2024-10-01T03:47:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/low-affinity-immunoglobulin-gamma-fc-region-receptor-ii-b-drugs-in-development/ 2024-10-01T03:04:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-21-receptor-drugs-in-development/ 2024-10-01T03:02:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tumor-necrosis-factor-receptor-superfamily-member-18-drugs-in-development/ 2024-10-01T03:50:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cysteinyl-leukotriene-receptor-1-drugs-in-development/ 2024-10-01T02:48:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/stimulator-of-interferon-genes-protein-drugs-in-development/ 2024-10-01T03:45:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/apolipoprotein-c-drugs-in-development/ 2024-10-01T02:30:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/melatonin-receptor-type-1a-drugs-in-development/ 2024-10-01T03:06:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alkaline-phosphatase-drugs-in-development/ 2024-10-01T02:28:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/prostacyclin-receptor-drugs-in-development/ 2024-10-01T03:22:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mineralocorticoid-receptor-drugs-in-development/ 2024-10-01T03:07:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/3-oxo-5-alpha-steroid-4-dehydrogenase-drugs-in-development/ 2024-10-01T02:26:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/beta-klotho-drugs-in-development/ 2024-10-01T02:42:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/corticotropin-releasing-factor-receptor-drugs-in-development/ 2024-10-01T02:47:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gap-junction-alpha-1-protein-drugs-in-development/ 2024-10-01T02:54:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/methyl-cpg-binding-protein-2-drugs-in-development/ 2024-10-01T03:07:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mitogen-activated-protein-kinase-kinase-kinase-5-drugs-in-development/ 2024-10-01T03:07:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/isocitrate-dehydrogenase-nadp-mitochondrial-drugs-in-development/ 2024-10-01T03:03:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/potassium-voltage-gated-channel-subfamily-kqt-member-4-drugs-in-development/ 2024-10-01T03:21:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/triggering-receptor-expressed-on-myeloid-cells-2-drugs-in-development/ 2024-10-01T03:49:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/igg-receptor-fcrn-large-subunit-p51-drugs-in-development/ 2024-10-01T02:58:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/map-kinase-interacting-serine-threonine-protein-kinase-1-drugs-in-development/ 2024-10-01T03:05:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mannan-binding-lectin-serine-protease-2-drugs-in-development/ 2024-10-01T03:05:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/complement-factor-b-drugs-in-development/ 2024-10-01T02:46:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/npc1-like-intracellular-cholesterol-transporter-1-drugs-in-development/ 2024-10-01T03:15:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/complement-c1s-subcomponent-drugs-in-development/ 2024-10-01T02:46:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pyruvate-kinase-pkm-drugs-in-development/ 2024-10-01T03:24:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glutamate-carboxypeptidase-2-drugs-in-development/ 2024-10-01T02:55:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alpha-1a-adrenergic-receptor-drugs-in-development/ 2024-10-01T02:29:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hiv-1-integrase-drugs-in-development/ 2024-10-01T02:58:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mucin-1-drugs-in-development/ 2024-10-01T03:08:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/transforming-growth-factor-beta-2-proprotein-drugs-in-development/ 2024-10-01T03:48:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/phosphodiesterase-3-drugs-in-development/ 2024-10-01T03:19:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-18-drugs-in-development/ 2024-10-01T03:01:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glial-cell-line-derived-neurotrophic-factor-drugs-in-development/ 2024-10-01T02:54:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/type-1-angiotensin-ii-receptor-drugs-in-development/ 2024-10-01T03:50:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cytochrome-p450-11b2-mitochondrial-drugs-in-development/ 2024-10-01T02:49:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/t-cell-specific-surface-glycoprotein-cd28-drugs-in-development/ 2024-10-01T03:46:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nociceptin-receptor-drugs-in-development/ 2024-10-01T03:16:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/melanocortin-receptor-4-drugs-in-development/ 2024-10-01T03:06:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/calpain-2-catalytic-subunit-drugs-in-development/ 2024-10-01T02:43:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/apelin-receptor-drugs-in-development/ 2024-10-01T02:30:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/x-linked-retinitis-pigmentosa-gtpase-regulator-drugs-in-development/ 2024-10-01T03:54:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/transient-receptor-potential-cation-channel-subfamily-v-member-1-drugs-in-development/ 2024-10-01T03:48:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cyclin-dependent-kinase-8-drugs-in-development/ 2024-10-01T02:48:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/transcriptional-enhancer-factor-tef-1-drugs-in-development/ 2024-10-01T03:48:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/map-kinase-interacting-serine-threonine-protein-kinase-2-drugs-in-development/ 2024-10-01T03:05:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mucosa-associated-lymphoid-tissue-lymphoma-translocation-protein-1-drugs-in-development/ 2024-10-01T03:08:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/prostaglandin-g-h-synthase-2-drugs-in-development/ 2024-10-01T03:22:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mitogen-activated-protein-kinase-interacting-kinase-drugs-in-development/ 2024-10-01T03:07:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dna-dependent-protein-kinase-catalytic-subunit-drugs-in-development/ 2024-10-01T02:50:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tyrosine-protein-kinase-btk-drugs-in-development/ 2024-10-01T03:51:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sodium-channel-protein-type-3-subunit-alpha-drugs-in-development/ 2024-10-01T03:30:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sodium-channel-protein-type-4-subunit-alpha-drugs-in-development/ 2024-10-01T03:30:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/serine-threonine-protein-kinase-plk-drugs-in-development/ 2024-10-01T03:28:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hemoglobin-subunit-beta-drugs-in-development/ 2024-10-01T02:57:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lymphotoxin-alpha-drugs-in-development/ 2024-10-01T03:05:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tgf-beta-receptor-type-1-drugs-in-development/ 2024-10-01T03:47:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cancer-testis-antigen-1-drugs-in-development/ 2024-10-01T02:43:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-1-alpha-drugs-in-development/ 2024-10-01T03:00:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/potassium-transporting-atpase-alpha-chain-1-drugs-in-development/ 2024-10-01T03:21:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/transient-receptor-potential-cation-channel-subfamily-c-trpc-drugs-in-development/ 2024-10-01T03:48:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amine-oxidase-flavin-containing-b-drugs-in-development/ 2024-10-01T02:29:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/phosphodiesterase-10-drugs-in-development/ 2024-10-01T03:19:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/proteinase-activated-receptor-2-drugs-in-development/ 2024-10-01T03:23:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/brain-derived-neurotrophic-factor-drugs-in-development/ 2024-10-01T02:42:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/angiotensin-converting-enzyme-drugs-in-development/ 2024-10-01T02:30:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acetyl-coa-carboxylase-drugs-in-development/ 2024-10-01T02:27:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/parathyroid-hormone-parathyroid-hormone-related-peptide-receptor-drugs-in-development/ 2024-10-01T03:18:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/diacylglycerol-o-acyltransferase-drugs-in-development/ 2024-10-01T02:49:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/5-hydroxytryptamine-receptor-4-drugs-in-development/ 2024-10-01T02:27:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adenosine-receptor-a3-drugs-in-development/ 2024-10-01T02:28:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/claudin-18-drugs-in-development/ 2024-10-01T02:45:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ccn-family-member-2-drugs-in-development/ 2024-10-01T02:46:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/somatostatin-receptor-type-5-drugs-in-development/ 2024-10-01T03:45:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/transmembrane-protease-serine-6-drugs-in-development/ 2024-10-01T03:49:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/growth-differentiation-factor-15-drugs-in-development/ 2024-10-01T02:56:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/myotonin-protein-kinase-drugs-in-development/ 2024-10-01T03:08:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/e3-ubiquitin-protein-ligase-cbl-b-drugs-in-development/ 2024-10-01T02:51:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/t-cell-surface-glycoprotein-cd4-drugs-in-development/ 2024-10-01T03:46:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/stearoyl-coa-desaturase-drugs-in-development/ 2024-10-01T03:45:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/voltage-dependent-t-type-calcium-channel-subunit-alpha-1h-drugs-in-development/ 2024-10-01T03:53:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/d1b-dopamine-receptor-drugs-in-development/ 2024-10-01T02:49:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sodium-channel-protein-type-2-subunit-alpha-drugs-in-development/ 2024-10-01T03:30:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ns5b-drugs-in-development/ 2024-10-01T03:16:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glutamate-receptor-ionotropic-nmda-2b-drugs-in-development/ 2024-10-01T02:55:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-10-drugs-in-development/ 2024-10-01T03:01:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/p2x-purinoceptor-7-drugs-in-development/ 2024-10-01T03:18:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/atrial-natriuretic-peptide-receptor-1-drugs-in-development/ 2024-10-01T02:40:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/transient-receptor-potential-cation-channel-subfamily-a-member-1-drugs-in-development/ 2024-10-01T03:48:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glucagon-like-peptide-1-drugs-in-development/ 2024-10-01T02:55:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sodium-glucose-cotransporter-2-drugs-in-development/ 2024-10-01T03:44:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/b-lymphocyte-antigen-cd20-drugs-in-development/ 2024-10-01T02:41:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/apolipoprotein-a-drugs-in-development/ 2024-10-01T02:30:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lysophosphatidic-acid-receptor-1-drugs-in-development/ 2024-10-01T03:05:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vasopressin-v1a-receptor-drugs-in-development/ 2024-10-01T03:53:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/5-hydroxytryptamine-receptor-6-drugs-in-development/ 2024-10-01T02:27:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/endothelin-receptor-type-b-drugs-in-development/ 2024-10-01T02:52:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-7-receptor-drugs-in-development/ 2024-10-01T03:03:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/activin-receptor-type-1-drugs-in-development/ 2024-10-01T02:27:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ectonucleotide-pyrophosphatase-phosphodiesterase-family-member-2-drugs-in-development/ 2024-10-01T02:51:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/angiopoietin-related-protein-3-drugs-in-development/ 2024-10-01T02:30:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/galectin-3-drugs-in-development/ 2024-10-01T02:54:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/histone-acetyltransferase-p300-drugs-in-development/ 2024-10-01T02:57:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ceramide-glucosyltransferase-drugs-in-development/ 2024-10-01T02:45:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/slc16-family-of-monocarboxylate-transporter-slc16-drugs-in-development/ 2024-10-01T03:29:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/30s-ribosomal-subunit-drugs-in-development/ 2024-10-01T02:26:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/serine-threonine-protein-kinase-b-raf-drugs-in-development/ 2024-10-01T03:27:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/endothelial-pas-domain-containing-protein-1-drugs-in-development/ 2024-10-01T02:51:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tumor-necrosis-factor-receptor-superfamily-member-16-drugs-in-development/ 2024-10-01T03:50:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/heat-shock-factor-protein-1-drugs-in-development/ 2024-10-01T02:56:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/transferrin-receptor-protein-1-drugs-in-development/ 2024-10-01T03:48:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/5-hydroxytryptamine-receptor-1b-drugs-in-development/ 2024-10-01T02:26:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/prostaglandin-e-synthase-drugs-in-development/ 2024-10-01T03:22:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/enoyl-acyl-carrier-protein-reductase-nadh-fabi-drugs-in-development/ 2024-10-01T02:52:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/antithrombin-iii-drugs-in-development/ 2024-10-01T02:30:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/orexin-receptor-type-2-drugs-in-development/ 2024-10-01T03:17:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nitric-oxide-synthase-drugs-in-development/ 2024-10-01T03:16:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adenosine-receptor-a1-drugs-in-development/ 2024-10-01T02:28:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/orexin-hypocretin-receptor-type-1-drugs-in-development/ 2024-10-01T03:17:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/purinergic-receptor-p2x-drugs-in-development/ 2024-10-01T03:24:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/free-fatty-acid-receptor-1-drugs-in-development/ 2024-10-01T02:53:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/transcriptional-coactivator-yap1-drugs-in-development/ 2024-10-01T03:48:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/f2r-receptor-drugs-in-development/ 2024-10-01T02:52:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glutamate-receptor-ionotropic-nmda-2-drugs-in-development/ 2024-10-01T02:55:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-33-drugs-in-development/ 2024-10-01T03:02:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aldehyde-dehydrogenase-drugs-in-development/ 2024-10-01T02:28:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/potassium-voltage-gated-channel-subfamily-kqt-member-2-drugs-in-development/ 2024-10-01T03:21:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/granulocyte-macrophage-colony-stimulating-factor-receptor-subunit-alpha-drugs-in-development/ 2024-10-01T02:56:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/serine-threonine-protein-kinase-pim-drugs-in-development/ 2024-10-01T03:28:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/p2x-purinoceptor-3-drugs-in-development/ 2024-10-01T03:17:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hypoxia-inducible-factor-1-alpha-drugs-in-development/ 2024-10-01T02:58:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fatty-acid-amide-hydrolase-drugs-in-development/ 2024-10-01T02:52:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sodium-bile-acid-cotransporter-drugs-in-development/ 2024-10-01T03:31:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/growth-hormone-secretagogue-receptor-type-1-drugs-in-development/ 2024-10-01T02:56:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/melanocyte-stimulating-hormone-receptor-drugs-in-development/ 2024-10-01T03:06:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/leukocyte-immunoglobulin-like-receptor-subfamily-b-member-2-drugs-in-development/ 2024-10-01T03:04:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lysophosphatidic-acid-receptor-drugs-in-development/ 2024-10-01T03:05:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mitogen-activated-protein-kinase-14-drugs-in-development/ 2024-10-01T03:07:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-6-receptor-subunit-alpha-drugs-in-development/ 2024-10-01T03:03:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/orai-calcium-release-activated-calcium-modulator-drugs-in-development/ 2024-10-01T03:17:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/isocitrate-dehydrogenase-nadp-cytoplasmic-drugs-in-development/ 2024-10-01T03:03:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/coagulation-factor-vii-drugs-in-development/ 2024-10-01T02:45:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nt-3-growth-factor-receptor-drugs-in-development/ 2024-10-01T03:16:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/three-prime-repair-exonuclease-1-drugs-in-development/ 2024-10-01T03:47:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rho-associated-protein-kinase-1-drugs-in-development/ 2024-10-01T03:26:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nonstructural-protein-5a-drugs-in-development/ 2024-10-01T03:16:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/baculoviral-iap-repeat-containing-protein-5-drugs-in-development/ 2024-10-01T02:41:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/complement-factor-d-drugs-in-development/ 2024-10-01T02:46:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hypoxia-inducible-factor-2-drugs-in-development/ 2024-10-01T02:58:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nonstructural-protein-5-drugs-in-development/ 2024-10-01T03:16:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vascular-endothelial-growth-factor-receptor-drugs-in-development/ 2024-10-01T03:53:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/thromboxane-a2-receptor-drugs-in-development/ 2024-10-01T03:47:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/angiotensin-converting-enzyme-2-drugs-in-development/ 2024-10-01T02:30:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kelch-like-ech-associated-protein-1-drugs-in-development/ 2024-10-01T03:03:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/superoxide-dismutase-cu-zn-drugs-in-development/ 2024-10-01T03:46:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/granulocyte-macrophage-colony-stimulating-factor-drugs-in-development/ 2024-10-01T02:56:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/activin-receptor-like-kinase-drugs-in-development/ 2024-10-01T02:27:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ectonucleotide-pyrophosphatase-phosphodiesterase-family-member-1-drugs-in-development/ 2024-10-01T02:51:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sodium-channel-protein-type-11-subunit-alpha-drugs-in-development/ 2024-10-01T03:30:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alpha-glucosidase-drugs-in-development/ 2024-10-01T02:29:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mitogen-activated-protein-kinase-3-drugs-in-development/ 2024-10-01T03:07:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/neuraminidase-drugs-in-development/ 2024-10-01T02:52:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/5-hydroxytryptamine-receptor-1d-drugs-in-development/ 2024-10-01T02:26:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/retinoic-acid-receptor-alpha-drugs-in-development/ 2024-10-01T03:26:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wilms-tumor-protein-drugs-in-development/ 2024-10-01T03:54:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/d4-dopamine-receptor-drugs-in-development/ 2024-10-01T02:49:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/somatostatin-receptor-type-4-drugs-in-development/ 2024-10-01T03:45:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gamma-aminobutyric-acid-type-b-receptor-subunit-drugs-in-development/ 2024-10-01T02:54:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/proprotein-convertase-subtilisin-kexin-type-9-drugs-in-development/ 2024-10-01T03:22:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/proto-oncogene-tyrosine-protein-kinase-receptor-ret-drugs-in-development/ 2024-10-01T03:23:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/with-h2o2-as-acceptor-one-oxygen-atom-of-which-is-incorporated-into-the-product-drugs-in-development/ 2024-10-01T03:54:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cyclin-dependent-kinase-7-drugs-in-development/ 2024-10-01T02:48:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/casein-kinase-1-drugs-in-development/ 2024-10-01T02:43:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glycogen-synthase-kinase-3-drugs-in-development/ 2024-10-01T02:55:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sodium-channel-protein-type-5-subunit-alpha-drugs-in-development/ 2024-10-01T03:30:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/heat-shock-protein-70-drugs-in-development/ 2024-10-01T02:56:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-10-receptor-drugs-in-development/ 2024-10-01T03:01:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cd40-ligand-drugs-in-development/ 2024-10-01T02:45:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aromatic-l-amino-acid-decarboxylase-drugs-in-development/ 2024-10-01T02:31:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/peroxisome-proliferator-activated-receptor-delta-drugs-in-development/ 2024-10-01T03:18:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dihydroorotate-dehydrogenase-quinone-mitochondrial-drugs-in-development/ 2024-10-01T02:50:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/low-density-lipoprotein-receptor-related-protein-drugs-in-development/ 2024-10-01T03:05:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/solute-carrier-family-22-member-12-drugs-in-development/ 2024-10-01T03:44:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/integrin-beta-1-drugs-in-development/ 2024-10-01T02:59:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ribonucleoside-diphosphate-reductase-drugs-in-development/ 2024-10-01T03:26:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/70s-ribosome-drugs-in-development/ 2024-10-01T02:27:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/receptor-tyrosine-protein-kinase-erbb-3-drugs-in-development/ 2024-10-01T03:25:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/c-x-c-chemokine-receptor-type-2-drugs-in-development/ 2024-10-01T02:47:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vasopressin-v2-receptor-drugs-in-development/ 2024-10-01T03:53:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/macrophage-migration-inhibitory-factor-drugs-in-development/ 2024-10-01T03:05:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/carbonic-anhydrase-drugs-in-development/ 2024-10-01T02:43:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ectonucleoside-triphosphate-diphosphohydrolase-1-drugs-in-development/ 2024-10-01T02:51:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sialic-acid-binding-ig-like-lectin-15-drugs-in-development/ 2024-10-01T03:29:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/potassium-voltage-gated-channel-subfamily-a-member-3-drugs-in-development/ 2024-10-01T03:21:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/angiopoietin-2-drugs-in-development/ 2024-10-01T02:29:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/receptor-tyrosine-protein-kinase-erbb-2-drugs-in-development/ 2024-10-01T03:25:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dual-specificity-mitogen-activated-protein-kinase-kinase-2-drugs-in-development/ 2024-10-01T02:50:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/plasminogen-activator-inhibitor-1-drugs-in-development/ 2024-10-01T03:20:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tumor-necrosis-factor-receptor-superfamily-member-1a-drugs-in-development/ 2024-10-01T03:50:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-6-drugs-in-development/ 2024-10-01T03:02:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/induced-myeloid-leukemia-cell-differentiation-protein-mcl-1-drugs-in-development/ 2024-10-01T02:59:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adp-ribosyl-cyclase-cyclic-adp-ribose-hydrolase-1-drugs-in-development/ 2024-10-01T02:28:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hiv-integrase-drugs-in-development/ 2024-10-01T02:58:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/5-hydroxytryptamine-receptor-3-drugs-in-development/ 2024-10-01T02:27:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-2-receptor-subunit-alpha-drugs-in-development/ 2024-10-01T03:02:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/e3-ubiquitin-protein-ligase-mdm2-drugs-in-development/ 2024-10-01T02:51:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/telomerase-reverse-transcriptase-drugs-in-development/ 2024-10-01T03:47:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/poly-adp-ribose-polymerase-1-drugs-in-development/ 2024-10-01T03:20:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/solute-carrier-family-2-facilitated-glucose-transporter-member-1-drugs-in-development/ 2024-10-01T03:44:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/c-c-chemokine-receptor-type-8-drugs-in-development/ 2024-10-01T02:44:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/plasmodium-falciparum-merozoite-surface-protein-1-drugs-in-development/ 2024-10-01T03:20:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lanosterol-14-alpha-demethylase-drugs-in-development/ 2024-10-01T03:04:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hepatocyte-growth-factor-drugs-in-development/ 2024-10-01T02:57:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tumor-necrosis-factor-receptor-superfamily-member-10a-tnfrsf10a-drugs-in-development/ 2024-10-01T03:50:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/endothelin-1-receptor-drugs-in-development/ 2024-10-01T02:51:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/histone-lysine-n-methyltransferase-ezh2-drugs-in-development/ 2024-10-01T02:58:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/phosphatidylinositol-4-5-bisphosphate-3-kinase-catalytic-subunit-gamma-isoform-drugs-in-development/ 2024-10-01T03:19:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/calcium-activated-neutral-protease-drugs-in-development/ 2024-10-01T02:43:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dual-specificity-mitogen-activated-protein-kinase-kinase-1-drugs-in-development/ 2024-10-01T02:50:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alpha-galactosidase-a-drugs-in-development/ 2024-10-01T02:29:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adenosine-receptor-a2b-drugs-in-development/ 2024-10-01T02:28:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/histone-acetyltransferase-drugs-in-development/ 2024-10-01T02:57:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mitogen-activated-protein-kinase-kinase-kinase-drugs-in-development/ 2024-10-01T03:07:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mitogen-activated-protein-kinase-kinase-kinase-kinase-1-drugs-in-development/ 2024-10-01T03:07:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/synaptic-vesicular-amine-transporter-drugs-in-development/ 2024-10-01T03:46:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-12-subunit-beta-drugs-in-development/ 2024-10-01T03:01:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/receptor-activity-modifying-protein-3-drugs-in-development/ 2024-10-01T03:25:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/serine-protein-kinase-atm-drugs-in-development/ 2024-10-01T03:27:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-23-subunit-alpha-drugs-in-development/ 2024-10-01T03:02:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/integrin-beta-3-drugs-in-development/ 2024-10-01T02:59:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sodium-and-chloride-dependent-glycine-transporter-1-drugs-in-development/ 2024-10-01T03:29:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/serine-threonine-protein-kinase-pim-3-drugs-in-development/ 2024-10-01T03:28:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mitogen-activated-protein-kinase-1-drugs-in-development/ 2024-10-01T03:07:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dual-specificity-tyrosine-phosphorylation-regulated-kinase-1a-drugs-in-development/ 2024-10-01T02:51:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/polycomb-protein-eed-drugs-in-development/ 2024-10-01T03:21:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/stromal-cell-derived-factor-1-drugs-in-development/ 2024-10-01T03:45:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/thymidylate-synthase-drugs-in-development/ 2024-10-01T03:47:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cytokine-receptor-common-subunit-gamma-drugs-in-development/ 2024-10-01T02:49:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/apoptosis-regulator-bcl-2-drugs-in-development/ 2024-10-01T02:30:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/insulin-like-growth-factor-1-receptor-drugs-in-development/ 2024-10-01T02:59:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/complement-c3-drugs-in-development/ 2024-10-01T02:46:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gamma-aminobutyric-acid-type-a-receptor-subunit-alpha-drugs-in-development/ 2024-10-01T02:54:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/angiopoietin-1-receptor-drugs-in-development/ 2024-10-01T02:29:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/prostaglandin-e2-receptor-ep4-subtype-drugs-in-development/ 2024-10-01T03:22:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sortilin-drugs-in-development/ 2024-10-01T03:45:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/muscarinic-acetylcholine-receptor-m3-drugs-in-development/ 2024-10-01T03:08:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/monoamine-oxidase-drugs-in-development/ 2024-10-01T03:07:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/platelet-derived-growth-factor-receptor-alpha-drugs-in-development/ 2024-10-01T03:20:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mitogen-activated-protein-kinase-kinase-kinase-kinase-drugs-in-development/ 2024-10-01T03:07:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hypocretin-receptor-drugs-in-development/ 2024-10-01T02:58:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rho-kinase-drugs-in-development/ 2024-10-01T03:26:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-17a-drugs-in-development/ 2024-10-01T03:01:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lysine-specific-histone-demethylase-1a-drugs-in-development/ 2024-10-01T03:05:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/prostate-specific-antigen-drugs-in-development/ 2024-10-01T03:22:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dna-directed-rna-polymerase-drugs-in-development/ 2024-10-01T02:50:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-1-beta-drugs-in-development/ 2024-10-01T03:00:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tyrosine-protein-kinase-syk-drugs-in-development/ 2024-10-01T03:51:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/integrin-alpha-4-drugs-in-development/ 2024-10-01T02:59:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glutamate-ionotropic-receptor-ampa-type-subunit-drugs-in-development/ 2024-10-01T02:55:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cyclin-dependent-kinase-9-drugs-in-development/ 2024-10-01T02:48:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/c-x-c-chemokine-receptor-type-4-drugs-in-development/ 2024-10-01T02:47:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/5-hydroxytryptamine-receptor-2c-drugs-in-development/ 2024-10-01T02:27:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/t-cell-immunoreceptor-with-ig-and-itim-domains-drugs-in-development/ 2024-10-01T03:46:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tissue-type-plasminogen-activator-drugs-in-development/ 2024-10-01T03:47:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/peroxisome-proliferator-activated-receptor-alpha-drugs-in-development/ 2024-10-01T03:18:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/estrogen-receptor-1-drugs-in-development/ 2024-10-01T02:52:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sialic-acid-binding-immunoglobulin-type-lectin-drugs-in-development/ 2024-10-01T03:29:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/leucine-rich-repeat-kinase-drugs-in-development/ 2024-10-01T03:04:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/peroxisome-proliferator-activated-receptor-gamma-drugs-in-development/ 2024-10-01T03:18:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/3-hydroxy-3-methylglutaryl-coenzyme-a-reductase-drugs-in-development/ 2024-10-01T02:26:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/coagulation-factor-x-drugs-in-development/ 2024-10-01T02:46:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nuclear-receptor-ror-gamma-drugs-in-development/ 2024-10-01T03:17:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/indoleamine-2-3-dioxygenase-1-drugs-in-development/ 2024-10-01T02:58:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cellular-tumor-antigen-p53-drugs-in-development/ 2024-10-01T02:45:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/muscarinic-acetylcholine-receptor-m1-drugs-in-development/ 2024-10-01T03:08:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-15-drugs-in-development/ 2024-10-01T03:01:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-1-receptor-associated-kinase-drugs-in-development/ 2024-10-01T03:00:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tyrosine-protein-phosphatase-non-receptor-type-1-drugs-in-development/ 2024-10-01T03:52:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-2-drugs-in-development/ 2024-10-01T03:02:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bile-acid-receptor-drugs-in-development/ 2024-10-01T02:42:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/guanylate-cyclase-drugs-in-development/ 2024-10-01T02:56:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/protein-glutamine-gamma-glutamyltransferase-2-drugs-in-development/ 2024-10-01T03:22:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alk-tyrosine-kinase-receptor-drugs-in-development/ 2024-10-01T02:28:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/growth-hormone-receptor-drugs-in-development/ 2024-10-01T02:56:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-15-receptor-subunit-alpha-drugs-in-development/ 2024-10-01T03:01:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lysosomal-acid-glucosylceramidase-drugs-in-development/ 2024-10-01T02:55:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/16s-ribosomal-rna-drugs-in-development/ 2024-10-01T02:26:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-12-receptor-drugs-in-development/ 2024-10-01T03:01:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hepatitis-a-virus-cellular-receptor-2-drugs-in-development/ 2024-10-01T02:57:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/psychosine-receptor-drugs-in-development/ 2024-10-01T03:24:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-6-receptor-drugs-in-development/ 2024-10-01T03:02:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bdnf-nt-3-growth-factors-receptor-drugs-in-development/ 2024-10-01T02:41:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/d1a-dopamine-receptor-drugs-in-development/ 2024-10-01T02:49:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fc-fragment-of-igg-low-affinity-iii-receptor-drugs-in-development/ 2024-10-01T02:53:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-4-receptor-subunit-alpha-drugs-in-development/ 2024-10-01T03:02:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-2-receptor-subunit-beta-drugs-in-development/ 2024-10-01T03:02:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/coagulation-factor-ix-drugs-in-development/ 2024-10-01T02:45:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/high-affinity-nerve-growth-factor-receptor-drugs-in-development/ 2024-10-01T02:57:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/phosphatidylinositol-4-5-bisphosphate-3-kinase-catalytic-subunit-alpha-isoform-drugs-in-development/ 2024-10-01T03:19:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/serine-threonine-protein-kinase-dclk1-drugs-in-development/ 2024-10-01T03:27:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tumor-associated-calcium-signal-transducer-2-drugs-in-development/ 2024-10-01T03:49:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/integrin-alpha-v-drugs-in-development/ 2024-10-01T02:59:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sodium-channel-protein-type-1-subunit-alpha-drugs-in-development/ 2024-10-01T03:30:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/toll-like-receptor-8-drugs-in-development/ 2024-10-01T03:48:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rho-guanine-nucleotide-exchange-factor-drugs-in-development/ 2024-10-01T03:26:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/beta-1-adrenergic-receptor-drugs-in-development/ 2024-10-01T02:41:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-23-drugs-in-development/ 2024-10-01T03:02:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/procollagen-proline-dioxygenase-drugs-in-development/ 2024-10-01T03:21:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/calcineurin-drugs-in-development/ 2024-10-01T02:42:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tyrosine-protein-kinase-mer-drugs-in-development/ 2024-10-01T03:51:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tumor-necrosis-factor-receptor-superfamily-member-1b-drugs-in-development/ 2024-10-01T03:50:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/phosphatidylinositol-4-5-bisphosphate-3-kinase-catalytic-subunit-delta-isoform-drugs-in-development/ 2024-10-01T03:19:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/serine-threonine-protein-kinase-atr-drugs-in-development/ 2024-10-01T03:27:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/receptor-tyrosine-protein-kinase-erbb-4-drugs-in-development/ 2024-10-01T03:25:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alpha-1-antitrypsin-drugs-in-development/ 2024-10-01T02:28:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/prothrombin-drugs-in-development/ 2024-10-01T03:23:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alpha-2-adrenergic-receptor-drugs-in-development/ 2024-10-01T02:29:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acetylcholinesterase-drugs-in-development/ 2024-10-01T02:27:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/poliovirus-receptor-drugs-in-development/ 2024-10-01T03:20:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/prolyl-endopeptidase-fap-drugs-in-development/ 2024-10-01T03:22:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gastric-inhibitory-polypeptide-receptor-drugs-in-development/ 2024-10-01T02:54:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/delta-type-opioid-receptor-drugs-in-development/ 2024-10-01T02:49:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vascular-endothelial-growth-factor-receptor-1-drugs-in-development/ 2024-10-01T03:52:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tumor-necrosis-factor-receptor-superfamily-member-9-drugs-in-development/ 2024-10-01T03:50:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/d3-dopamine-receptor-drugs-in-development/ 2024-10-01T02:49:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cgmp-specific-3-5-cyclic-phosphodiesterase-drugs-in-development/ 2024-10-01T02:45:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nacht-lrr-and-pyd-domains-containing-protein-3-drugs-in-development/ 2024-10-01T03:09:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/granulocyte-colony-stimulating-factor-receptor-drugs-in-development/ 2024-10-01T02:56:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alpha-1-adrenergic-receptor-drugs-in-development/ 2024-10-01T02:28:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vascular-endothelial-growth-factor-b-drugs-in-development/ 2024-10-01T03:52:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-17-drugs-in-development/ 2024-10-01T03:01:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fibroblast-growth-factor-receptor-2-drugs-in-development/ 2024-10-01T02:53:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interferon-alpha-beta-receptor-2-drugs-in-development/ 2024-10-01T03:00:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/t-lymphocyte-activation-antigen-cd86-drugs-in-development/ 2024-10-01T03:46:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adenosine-receptor-a2a-drugs-in-development/ 2024-10-01T02:28:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/5-nucleotidase-drugs-in-development/ 2024-10-01T02:26:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lymphocyte-activation-gene-3-protein-drugs-in-development/ 2024-10-01T03:05:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tumor-necrosis-factor-receptor-superfamily-member-4-drugs-in-development/ 2024-10-01T03:50:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fibroblast-growth-factor-receptor-3-drugs-in-development/ 2024-10-01T02:53:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/transient-receptor-potential-cation-channel-subfamily-m-member-8-drugs-in-development/ 2024-10-01T03:48:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/phosphodiesterase-4-drugs-in-development/ 2024-10-01T03:19:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/3-5-cyclic-amp-phosphodiesterase-drugs-in-development/ 2024-10-01T02:26:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sodium-dependent-noradrenaline-transporter-drugs-in-development/ 2024-10-01T03:30:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sodium-glucose-cotransporter-1-drugs-in-development/ 2024-10-01T03:31:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cyclin-dependent-kinase-6-drugs-in-development/ 2024-10-01T02:48:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interferon-alpha-beta-receptor-1-drugs-in-development/ 2024-10-01T03:00:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mast-stem-cell-growth-factor-receptor-kit-drugs-in-development/ 2024-10-01T03:05:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fibroblast-growth-factor-receptor-1-drugs-in-development/ 2024-10-01T02:53:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/macrophage-colony-stimulating-factor-1-receptor-drugs-in-development/ 2024-10-01T03:05:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/toll-like-receptor-5-drugs-in-development/ 2024-10-01T03:48:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/synaptosomal-associated-protein-25-drugs-in-development/ 2024-10-01T03:46:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sigma-non-opioid-intracellular-receptor-1-drugs-in-development/ 2024-10-01T03:29:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dipeptidyl-peptidase-4-drugs-in-development/ 2024-10-01T02:50:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sodium-channel-protein-type-8-subunit-alpha-drugs-in-development/ 2024-10-01T03:30:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/coagulation-factor-viii-drugs-in-development/ 2024-10-01T02:46:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/beta-2-adrenergic-receptor-drugs-in-development/ 2024-10-01T02:41:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adenosine-monophosphate-activated-protein-kinase-drugs-in-development/ 2024-10-01T02:28:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kappa-type-opioid-receptor-drugs-in-development/ 2024-10-01T03:03:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sodium-channel-protein-type-9-subunit-alpha-drugs-in-development/ 2024-10-01T03:30:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/receptor-interacting-serine-threonine-protein-kinase-2-drugs-in-development/ 2024-10-01T03:25:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cystic-fibrosis-transmembrane-conductance-regulator-drugs-in-development/ 2024-10-01T02:48:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/steryl-sulfatase-drugs-in-development/ 2024-10-01T03:45:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hepatocyte-growth-factor-receptor-drugs-in-development/ 2024-10-01T02:57:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/type-2-angiotensin-ii-receptor-drugs-in-development/ 2024-10-01T03:50:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cytotoxic-t-lymphocyte-protein-4-drugs-in-development/ 2024-10-01T02:49:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amyloid-beta-precursor-protein-drugs-in-development/ 2024-10-01T02:29:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/microtubule-associated-protein-tau-drugs-in-development/ 2024-10-01T03:07:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/prostaglandin-f2-alpha-receptor-drugs-in-development/ 2024-10-01T03:22:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sodium-dependent-dopamine-transporter-drugs-in-development/ 2024-10-01T03:30:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/androgen-receptor-drugs-in-development/ 2024-10-01T02:29:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vascular-endothelial-growth-factor-c-drugs-in-development/ 2024-10-01T03:52:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tumor-necrosis-factor-receptor-superfamily-member-5-drugs-in-development/ 2024-10-01T03:50:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/leukocyte-surface-antigen-cd47-drugs-in-development/ 2024-10-01T03:04:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glucocorticoid-receptor-drugs-in-development/ 2024-10-01T02:55:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/5-hydroxytryptamine-receptor-1-drugs-in-development/ 2024-10-01T02:26:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/udp-3-o-3-hydroxymyristoyl-n-acetylglucosamine-deacetylase-drugs-in-development/ 2024-10-01T03:52:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/prostaglandin-g-h-synthase-1-drugs-in-development/ 2024-10-01T03:22:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gtpase-kras-drugs-in-development/ 2024-10-01T02:56:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/receptor-type-tyrosine-protein-kinase-flt3-drugs-in-development/ 2024-10-01T03:25:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/insulin-receptor-drugs-in-development/ 2024-10-01T02:59:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/5-hydroxytryptamine-receptor-2a-drugs-in-development/ 2024-10-01T02:26:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/interleukin-13-drugs-in-development/ 2024-10-01T03:01:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/butyrophilin-subfamily-3-member-a1-drugs-in-development/ 2024-10-01T02:42:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/purinergic-receptor-p2y-drugs-in-development/ 2024-10-01T03:24:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mu-type-opioid-receptor-drugs-in-development/ 2024-10-01T03:08:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biomarin-lays-off-225-employees-in-restructuring-efforts/ 2024-08-29T15:41:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-teams-up-with-lindy-biosciences-to-improve-biologic-delivery/ 2024-08-29T14:30:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/repare-therapeutics-cuts-quarter-of-its-workforce-and-prioritises-clinical-assets/ 2024-08-29T13:05:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tc-biopharm-secures-european-patent/ 2024-08-29T10:48:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biocon-agreement-janssen-bmab-1200/ 2024-08-29T10:24:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/us-negotiations-first-round-6bn-medicare-savings/ 2024-08-29T10:09:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/flagship-pfizer-partnership-targets/ 2024-08-29T08:12:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/japan-gsks-nucala-rhinosinusitis-nasal-polyps/ 2024-08-29T08:06:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-most-expensive-drugs-in-the-us/ 2024-08-28T20:06:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-teams-up-with-lncrna-focused-nextrna-in-547m-deal/ 2024-08-29T08:14:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/arcus-biosciences-obtains-loan-facility-with-hercules-capital-worth-250m/ 2024-08-28T18:27:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/soleno-wins-fda-priority-review-for-prader-willi-therapy/ 2024-08-28T14:07:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/oesophageal-cancer-the-global-clinical-trials-landscape-in-2024/ 2024-08-28T12:23:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/navigator-100m-antibody-therapeutics/ 2024-08-28T10:19:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-astellas-padcev-regimen/ 2024-08-28T10:13:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-digital-healthcare-platform/ 2024-08-28T08:28:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-zepbound-self-pay-patients/ 2024-08-28T08:19:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-upgrades-approval-for-jjs-rybrevant-chemotherapy-combination-in-nsclc/ 2024-08-27T19:43:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/singapore-approves-mpox-vaccine-as-it-adds-border-infection-checks/ 2024-08-27T13:56:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/supply-chain-digitalisation-dont-let-the-knock-on-benefits-pass-you-by/ 2024-08-27T15:43:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/shortages-improve-lilly-glp-1-weight-loss/ 2024-08-27T13:01:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/iasp-2024-opioid-use-chronic-pain-compound-addiction/ 2024-08-27T12:34:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/what-is-mpox-and-how-big-of-a-threat-is-it/ 2024-08-27T11:20:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-approval-roche-piasky/ 2024-08-27T10:20:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-beigene-cll-treatment/ 2024-08-27T10:14:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sifi-akantior-ec-approval/ 2024-08-27T08:16:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ucb-divest-business-china/ 2024-08-27T07:23:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-snags-european-approval-for-pulmonary-arterial-hypertension-therapy/ 2024-08-26T20:02:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celltrion-steqeyma-ec-approval/ 2024-08-26T10:09:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/invenra-antibody-fda-designations/ 2024-08-26T09:35:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-approval-genfleet-fulzerasib/ 2024-08-26T08:26:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/janssen-balversa-ec-approval/ 2024-08-26T08:20:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-may-pull-plug-on-uk-vaccine-manufacturing-plans/ 2024-08-23T15:11:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-doubles-down-on-oblique-partnership-for-antibody-generation/ 2024-08-23T14:18:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jazzs-cannabidiol-therapy-flunks-in-japanese-phase-iii-trial/ 2024-08-23T13:23:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/a-comprehensive-guide-to-supply-chain-management-for-specialty-drugs/ 2024-08-27T10:26:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rafael-cyclo-merger-deal/ 2024-08-23T10:18:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vion-biosciences-acquires-echelon/ 2024-08-23T10:14:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approval-vaccines-covid/ 2024-08-23T15:12:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-versant-launch-borealis/ 2024-08-23T07:54:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/verve-therapeutics-gets-grant-for-gene-editing-compositions-to-lower-ldl-cholesterol-levels/ 2024-08-23T04:15:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/codiak-biosciences-gets-grant-for-extracellular-vesicles-for-disease-treatment-and-prevention/ 2024-08-23T04:14:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/frequency-therapeutics-gets-grant-for-oligonucleotide-compositions-for-treating-mrna-related-disorders/ 2024-08-23T04:14:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/orion-gets-grant-for-cyp11a1-inhibitors-for-treating-prostate-cancer/ 2024-08-23T04:13:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/optibiotix-health-gets-grant-for-modified-prebiotic-oligosaccharides-with-increased-sweetness-value/ 2024-08-23T04:13:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aquestive-therapeutics-gets-grant-for-enhanced-pharmaceutical-compositions-for-active-component-permeation/ 2024-08-23T04:13:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ocular-therapeutix-gets-grant-for-intracanalicular-injectable-applicator-device-for-drug-delivery/ 2024-08-23T04:13:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lyra-therapeutics-gets-grant-for-coated-scaffold-for-treating-chronic-sinusitis/ 2024-08-23T04:12:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/acorda-therapeutics-gets-grant-for-sustained-release-4-aminopyridine-tablets-for-neurological-disorders/ 2024-08-23T04:12:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/regulus-therapeutics-gets-grant-for-inhibitors-of-mir-122-for-hepatitis-c-treatment/ 2024-08-23T04:12:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chemomab-therapeutics-gets-grant-for-anti-ccl24-antibodies-for-treating-hepatic-pathologies/ 2024-08-23T04:12:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/genovis-gets-grant-for-streptococcal-proteases-for-cleaving-human-igg1-in-vitro/ 2024-08-23T04:11:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/travere-therapeutics-gets-grant-for-pegylation-method-for-mutated-human-cystathionine-synthase-protein/ 2024-08-23T04:11:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/assembly-biosciences-gets-grant-for-heteroaryl-carboxamide-compounds-for-treating-hepatitis-b/ 2024-08-23T04:10:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eiger-biopharmaceuticals-gets-grant-for-combination-treatment-for-hepatitis-delta-virus-hdv-infection/ 2024-08-23T04:10:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nkarta-gets-grant-for-genetically-engineered-nk-cells-targeting-cd70-for-immunotherapy/ 2024-08-23T04:10:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cocrystal-pharma-gets-grant-for-influenza-virus-replication-inhibitors-and-treatments/ 2024-08-23T04:10:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aurora-cannabis-gets-grant-for-cannabis-plant-breeding-for-day-length-neutral-phenotype/ 2024-08-23T04:09:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sonnet-biotherapeutics-gets-grant-for-albumin-binding-domain-fusion-protein-for-therapeutic-applications/ 2024-08-23T04:09:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/american-well-gets-grant-for-telehealth-communication-device-with-image-and-audio-capabilities/ 2024-08-23T04:09:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/athira-pharma-gets-grant-for-method-for-treating-parkinson-s-and-lewy-body-diseases/ 2024-08-23T04:09:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anaptysbio-gets-grant-for-il-33-binding-agent-for-treating-autoimmune-diseases/ 2024-08-23T04:08:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/scpharmaceuticals-gets-grant-for-liquid-pharmaceutical-formulation-for-treating-congestion-and-edema/ 2024-08-23T04:08:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sana-biotechnology-gets-grant-for-engineered-t-cells-with-hypoimmunogenic-properties-and-cars/ 2024-08-23T04:08:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inventiva-gets-grant-for-compounds-of-formula-i-for-pharmaceutical-applications/ 2024-08-23T04:08:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arcutis-biotherapeutics-gets-grant-for-method-to-reduce-roflumilast-skin-penetration-lag-time/ 2024-08-23T04:07:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/entrada-therapeutics-gets-grant-for-compounds-for-treating-mitochondrial-neurogastrointestinal-encephalopathy-syndrome/ 2024-08-23T04:07:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tiziana-life-sciences-gets-grant-for-nanoparticle-formulation-of-dactinomycin-for-treating-mds/ 2024-08-23T04:06:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/photocure-gets-grant-for-photodynamic-therapy-method-for-treating-bladder-cancer/ 2024-08-23T04:06:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/evofem-biosciences-gets-grant-for-contraceptive-microbicide-composition-for-pregnancy-prevention-and-disease-reduction/ 2024-08-23T04:06:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hikma-pharmaceuticals-gets-grant-for-ready-to-administer-hydromorphone-intravenous-liquid-formulation/ 2024-08-23T04:06:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fennec-pharmaceuticals-gets-grant-for-reducing-ototoxicity-in-patients-receiving-platinum-based-chemotherapy/ 2024-08-23T04:05:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/peptidream-gets-grant-for-method-for-producing-peptides-using-protected-amino-acids/ 2024-08-23T04:05:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chimerix-gets-grant-for-cancer-treatment-using-specific-pharmaceutical-compounds/ 2024-08-23T04:05:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/madrigal-pharmaceuticals-gets-grant-for-method-for-treating-fatty-liver-disease-with-pyridazinone-compounds/ 2024-08-23T04:05:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biocon-gets-grant-for-humanized-igg1-anti-cd6-monoclonal-antibody/ 2024-08-23T04:04:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/regenxbio-gets-grant-for-treatment-method-for-mucopolysaccharidosis-ii-using-iduronate-2-sulfatase/ 2024-08-23T04:04:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/stealth-biotherapeutics-gets-grant-for-peptide-generation-methods-and-specific-peptide-compounds/ 2024-08-23T04:04:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bioxcel-therapeutics-gets-grant-for-methods-for-treating-agitation-with-dexmedetomidine-without-sedation/ 2024-08-23T04:04:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cipla-gets-grant-for-blister-strip-dispenser-with-waste-dose-collection-mechanism/ 2024-08-23T04:03:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vaxcyte-gets-grant-for-immunogenic-compositions-with-non-natural-amino-acid-conjugates/ 2024-08-23T04:03:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ginkgo-bioworks-gets-grant-for-modified-aav-capsid-proteins-and-virus-vectors/ 2024-08-23T04:02:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/melinta-therapeutics-gets-grant-for-treating-infections-in-obese-patients-with-delafloxacin/ 2024-08-23T04:02:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mind-medicine-mindmed-gets-grant-for-lsd-orally-disintegrating-tablet-formulation-and-manufacturing-method/ 2024-08-23T04:02:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/23andme-holding-gets-grant-for-method-for-determining-genetic-relatedness-using-identity-by-descent/ 2024-08-23T04:02:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/theravance-biopharma-gets-grant-for-neprilysin-inhibiting-compounds-for-treating-related-diseases/ 2024-08-23T04:01:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bridgebio-pharma-gets-grant-for-high-load-tablet-formulations-of-ag10/ 2024-08-23T04:01:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/catalent-gets-grant-for-activated-formylglycine-generating-enzymes-for-protein-production/ 2024-08-23T04:01:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alkermes-gets-grant-for-compounds-for-treating-narcolepsy-or-cataplexy-2/ 2024-08-23T04:01:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/memorial-sloan-kettering-cancer-center-gets-grant-for-chimeric-newcastle-disease-virus-for-cancer-treatment/ 2024-08-23T04:00:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/otsuka-gets-grant-for-ingestible-event-markers-with-advanced-circuitry-and-materials/ 2024-08-23T04:00:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/harrow-health-gets-grant-for-remote-eye-image-capture-and-data-anonymization-system/ 2024-08-23T03:59:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/perrigo-co-gets-grant-for-nutritional-composition-for-cognitive-function-and-neuron-health-2/ 2024-08-23T03:59:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/halozyme-therapeutics-gets-grant-for-modified-ph20-hyaluronidase-polypeptides-with-enhanced-stability-and-activity/ 2024-08-23T03:59:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ani-pharmaceuticals-gets-grant-for-method-for-storing-and-warming-sterile-corticotropin-composition/ 2024-08-23T03:59:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/larimar-therapeutics-gets-grant-for-methods-for-measuring-frataxin-protein-activity-and-modulation/ 2024-08-23T03:58:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/curevac-gets-grant-for-mrna-vaccines-for-stimulating-immune-response-in-elderly-patients/ 2024-08-23T03:58:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cspc-pharmaceutical-group-gets-grant-for-lsd1-inhibitor-compound-and-its-crystal-form/ 2024-08-23T03:58:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/syndax-pharmaceuticals-gets-grant-for-patient-selection-for-hdac-inhibitor-combination-cancer-therapy/ 2024-08-23T03:58:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zydus-lifesciences-gets-grant-for-liquid-oral-formulation-of-sildenafil-for-medical-treatment/ 2024-08-23T03:57:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/heidelberg-pharma-gets-grant-for-methods-for-enhancing-car-immune-cell-acceptance-using-anti-cd5-adcs/ 2024-08-23T03:57:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amneal-pharmaceuticals-gets-grant-for-gastroretentive-tablet-for-targeted-drug-release/ 2024-08-23T03:56:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/veradigm-gets-grant-for-securing-prescription-data-on-a-computer-network/ 2024-08-23T03:56:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/antisense-therapeutics-gets-grant-for-method-for-treating-muscular-dystrophy-using-oligonucleotides/ 2024-08-23T03:56:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/avadel-pharmaceuticals-gets-grant-for-gamma-hydroxybutyrate-formulations-for-treating-narcolepsy-symptoms/ 2024-08-23T03:56:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/boston-children-s-hospital-gets-grant-for-method-for-inferring-cell-lineages-using-mitochondrial-mutations/ 2024-08-23T03:55:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zhejiang-medicine-gets-grant-for-method-for-preparing-nemonoxacin-malate-active-pharmaceutical-ingredient/ 2024-08-23T03:55:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/children-s-medical-center-gets-grant-for-immunogenic-composition-with-multiple-distinct-peptide-antigens/ 2024-08-23T03:55:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alector-gets-grant-for-transgenic-animals-for-screening-human-gene-modulating-agents/ 2024-08-23T03:55:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/springworks-therapeutics-gets-grant-for-oral-dosage-form-of-mirdametinib-for-cancer-treatment/ 2024-08-23T03:54:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/community-health-systems-gets-grant-for-remote-sleep-diagnostic-system-with-biometric-identification/ 2024-08-23T03:54:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arcus-biosciences-gets-grant-for-solid-forms-of-compound-i-and-their-uses/ 2024-08-23T03:54:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wuxi-apptec-gets-grant-for-macrocyclic-compounds-for-treating-cancer/ 2024-08-23T03:54:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/corvus-pharmaceuticals-gets-grant-for-cancer-treatment-using-a2a-receptor-antagonists-and-pd-1-inhibitors/ 2024-08-23T03:53:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pliant-therapeutics-gets-grant-for-integrin-inhibitors-for-treating-fibrotic-diseases/ 2024-08-23T03:53:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eagle-pharmaceuticals-gets-grant-for-amisulpride-for-treating-postoperative-nausea-and-vomiting/ 2024-08-23T03:52:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eyenovia-gets-grant-for-ophthalmic-drug-delivery-using-a-charge-isolated-ejector-mechanism/ 2024-08-23T03:52:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/intellia-therapeutics-gets-grant-for-genome-editing-for-immuno-oncology-targeting-b2m-sequences/ 2024-08-23T03:52:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/beyondspring-gets-grant-for-crystalline-form-of-plinabulin-for-therapeutic-use/ 2024-08-23T03:52:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/betta-pharmaceuticals-gets-grant-for-crystal-form-of-a-specific-pharmaceutical-compound/ 2024-08-23T03:51:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/crispr-therapeutics-gets-grant-for-gene-editing-for-angptl3-related-diseases-using-nanoparticles/ 2024-08-23T03:51:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/molecular-templates-gets-grant-for-t-cell-epitope-delivering-polypeptides-for-targeted-cell-killing/ 2024-08-23T03:51:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ocuphire-pharma-gets-grant-for-treatment-of-presbyopia-using-phentolamine-eye-drops/ 2024-08-23T03:51:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/annexon-gets-grant-for-anti-c1q-antibody-fab-fragments-for-inhibiting-synapse-loss/ 2024-08-23T03:50:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/proqr-therapeutics-gets-grant-for-antisense-oligonucleotides-for-targeted-rna-editing/ 2024-08-23T03:50:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/fate-therapeutics-gets-grant-for-immune-cell-modulation-for-enhanced-adoptive-cell-therapies/ 2024-08-23T03:50:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/editas-medicine-gets-grant-for-crispr-methods-for-increasing-fetal-hemoglobin-expression/ 2024-08-23T03:50:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/celldex-therapeutics-gets-grant-for-antibodies-for-treating-eosinophil-and-mast-cell-disorders/ 2024-08-23T03:49:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/actinium-pharmaceuticals-gets-grant-for-humanized-anti-human-cd45-antibodies-and-compositions/ 2024-08-23T03:49:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/towa-pharmaceutical-gets-grant-for-method-for-efficient-resin-supply-using-cartridge-replacement/ 2024-08-23T03:48:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/navidea-biopharmaceuticals-gets-grant-for-treatment-of-flaviviridae-family-virus-infections/ 2024-08-23T03:48:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/medicinova-gets-grant-for-method-for-preventing-cancer-metastasis-using-ibudilast/ 2024-08-23T03:48:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/innate-pharma-gets-grant-for-cancer-treatment-using-anti-nkg2a-antibodies/ 2024-08-23T03:48:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nurix-therapeutics-gets-grant-for-combination-therapies-using-cbl-b-inhibitors-for-cancer-treatment/ 2024-08-23T03:47:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/epivax-gets-grant-for-chimeric-polypeptides-with-immunoglobulin-fragments-and-active-molecules/ 2024-08-23T03:47:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cytokinetics-gets-grant-for-method-for-treating-heart-failure-using-cardiac-sarcomere-activator/ 2024-08-23T03:47:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/immunic-gets-grant-for-crystalline-polymorph-a-of-calcium-salt-compound/ 2024-08-23T03:47:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sword-health-gets-grant-for-motion-tracking-system-adjustment-using-sensor-orientation-differences/ 2024-08-23T03:46:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kobayashi-pharmaceutical-gets-grant-for-interdental-cleaning-tool-with-varying-bristle-hardness-2/ 2024-08-23T03:46:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cyclerion-therapeutics-gets-grant-for-process-for-preparing-soluble-guanylate-cyclase-stimulators/ 2024-08-23T03:46:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aligos-therapeutics-gets-grant-for-inhibitors-of-pd-1-pd-l1-interaction-for-disease-treatment/ 2024-08-23T03:46:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/beam-therapeutics-gets-grant-for-editing-mutations-for-treating-sickle-cell-disease/ 2024-08-23T03:45:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/equillium-gets-grant-for-method-for-treating-alopecia-using-c-cytokine-antagonist-peptides/ 2024-08-23T03:45:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vir-biotechnology-gets-grant-for-antibodies-for-neutralizing-hepatitis-b-and-d-viruses-2/ 2024-08-23T03:44:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vir-biotechnology-gets-grant-for-antibodies-for-neutralizing-hepatitis-b-and-d-viruses/ 2024-08-23T03:44:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ikena-oncology-gets-grant-for-ahr-agonists-for-treating-angiogenesis-and-inflammatory-disorders/ 2024-08-23T03:45:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rapt-therapeutics-gets-grant-for-crystalline-ccr4-antagonist-compound-and-oral-dosage-forms/ 2024-08-23T03:43:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cue-biopharma-gets-grant-for-t-cell-modulatory-polypeptides-for-treating-type-1-diabetes/ 2024-08-23T03:43:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/denali-therapeutics-gets-grant-for-crystalline-forms-of-a-specific-pharmaceutical-compound/ 2024-08-23T03:43:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/c4-therapeutics-gets-grant-for-degronimers-for-targeted-protein-degradation/ 2024-08-23T03:43:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/revolution-medicines-gets-grant-for-macrocyclic-compounds-for-modulating-protein-interactions/ 2024-08-23T03:42:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/spruce-biosciences-gets-grant-for-treatment-of-congenital-adrenal-hyperplasia-cah-using-novel-compounds/ 2024-08-23T03:42:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/recursion-pharmaceuticals-gets-grant-for-method-for-identifying-target-proteins-using-ligands/ 2024-08-23T03:42:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/atea-pharmaceuticals-gets-grant-for-hemi-sulfate-salt-for-treating-hepatitis-c-infection/ 2024-08-23T03:42:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ose-immunotherapeutics-gets-grant-for-ready-to-use-peptide-emulsion-manufacturing-method-and-product/ 2024-08-23T03:41:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abivax-gets-grant-for-inflammatory-disease-treatment-using-specific-compounds/ 2024-08-23T03:41:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/avidity-biosciences-gets-grant-for-binding-moiety-conjugated-to-modified-polynucleic-acid-and-polymer/ 2024-08-23T03:41:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aldeyra-therapeutics-gets-grant-for-aldehyde-scavenging-small-molecule-therapeutics-for-disease-treatment/ 2024-08-23T03:41:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/radius-health-gets-grant-for-estrogen-receptor-modulators-for-treating-related-diseases/ 2024-08-23T03:40:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gsk-gets-grant-for-modular-system-for-sterilizing-containers-using-pressurized-fluid/ 2024-08-23T03:40:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eli-lilly-and-co-gets-grant-for-automatic-medication-injection-device-with-syringe-carrier-assembly/ 2024-08-23T03:39:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/teva-pharmaceutical-industries-gets-grant-for-asthma-exacerbation-probability-determination-system-and-method/ 2024-08-23T03:39:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shilpa-medicare-gets-grant-for-liquid-pharmaceutical-composition-for-oral-delivery-of-vigabatrin/ 2024-08-23T03:39:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/iovance-biotherapeutics-gets-grant-for-methods-for-expanding-therapeutic-tumor-infiltrating-lymphocytes-tils/ 2024-08-23T03:39:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zhejiang-huahai-pharmaceutical-gets-grant-for-pregabalin-lactam-methylene-dimer-and-its-preparation-method/ 2024-08-23T03:38:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/geron-gets-grant-for-crystalline-solids-of-specific-palmitoyl-amido-compounds/ 2024-08-23T03:38:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/celltrion-gets-grant-for-stable-liquid-antibody-formulation-for-subcutaneous-administration/ 2024-08-23T03:38:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/humanwell-healthcare-group-gets-grant-for-bioavailable-liquid-compositions-for-respiratory-relief/ 2024-08-23T03:38:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arbutus-biopharma-gets-grant-for-liver-targeting-sirna-conjugates-for-treating-hepatitis-diseases/ 2024-08-23T03:37:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zeria-pharmaceutical-gets-grant-for-antibody-molecules-targeting-tumor-necrosis-factor-alpha-tnfa/ 2024-08-23T03:37:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/argenx-gets-grant-for-combination-therapies-for-treating-asthma-using-bispecific-antibodies/ 2024-08-23T03:37:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/orexo-gets-grant-for-method-for-treating-opioid-dependence-with-alcohol-management/ 2024-08-23T03:37:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/senju-pharmaceutical-gets-grant-for-method-for-differentiating-stem-cells-into-retinal-ganglion-cells/ 2024-08-23T03:36:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sorrento-therapeutics-gets-grant-for-sustained-release-corticosteroid-compositions-for-pain-treatment/ 2024-08-23T03:36:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/enanta-pharmaceuticals-gets-grant-for-treatment-of-non-alcoholic-fatty-liver-disease-using-specific-compounds/ 2024-08-23T03:35:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/precigen-gets-grant-for-genetically-modified-methanotrophs-producing-1-4-butanediol-from-methane/ 2024-08-23T03:35:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/twist-bioscience-gets-grant-for-optimized-antibodies-targeting-ace2-protein-for-sars-cov-2/ 2024-08-23T03:35:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cartesian-therapeutics-gets-grant-for-chimeric-antigen-receptors-targeting-b-cell-maturation-antigen/ 2024-08-23T03:35:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sun-pharmaceutical-industries-gets-grant-for-deuterated-d-serine-for-treating-neurological-disorders/ 2024-08-23T03:34:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kissei-pharmaceutical-gets-grant-for-method-for-treating-endometriosis-with-gnrh-antagonist/ 2024-08-23T03:34:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amarin-corp-gets-grant-for-reducing-heart-failure-risk-using-eicosapentaenoic-acid/ 2024-08-23T03:34:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ptc-therapeutics-gets-grant-for-method-for-treating-pancreatic-cancer-using-tubulin-inhibitors/ 2024-08-23T03:34:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/esperion-therapeutics-gets-grant-for-methods-for-preparing-8-hydroxy-2-2-14-14-tetramethylpentadecanedioic-acid/ 2024-08-23T03:33:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hu-group-gets-grant-for-method-for-measuring-lectin-binding-substances-in-samples/ 2024-08-23T03:33:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/teladoc-health-gets-grant-for-telepresence-network-management-system-for-healthcare-facilities/ 2024-08-23T03:33:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/arvinas-gets-grant-for-crystalline-form-of-compound-a-for-therapeutic-use/ 2024-08-23T03:33:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/grunenthal-gets-grant-for-pain-treatment-compounds-inhibiting-nav1-8/ 2024-08-23T03:32:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/purdue-pharma-gets-grant-for-cannabinoid-based-oral-pharmaceutical-composition-for-pain-management/ 2024-08-23T03:32:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/silence-therapeutics-gets-grant-for-nucleic-acid-for-inhibiting-target-gene-expression-2/ 2024-08-23T03:31:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ultragenyx-pharmaceutical-gets-grant-for-engineered-cell-lines-for-enhanced-raav-production/ 2024-08-23T03:31:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glycomimetics-gets-grant-for-e-selectin-antagonists-for-cancer-treatment-and-prevention/ 2024-08-23T03:31:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sosei-group-gets-grant-for-compounds-for-treating-muscarinic-receptor-mediated-diseases/ 2024-08-23T03:31:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/adverum-biotechnologies-gets-grant-for-modified-aav-capsid-for-enhanced-retinal-cell-targeting/ 2024-08-23T03:30:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sutro-biopharma-gets-grant-for-antibodies-targeting-b-cell-maturation-antigen-bcma/ 2024-08-23T03:30:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/tonix-pharmaceuticals-holding-gets-grant-for-treatment-of-depression-using-cyclobenzaprine-in-fibromyalgia-patients/ 2024-08-23T03:30:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/blueprint-medicines-gets-grant-for-selective-map4k1-inhibitors-for-treating-cancer-and-viral-infections/ 2024-08-23T03:30:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/therapeutic-solutions-international-gets-grant-for-method-for-reducing-lung-inflammation-using-stem-cells-and-t-regulatory-cells/ 2024-08-23T03:29:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eisai-gets-grant-for-therapeutic-agent-for-treating-fatty-liver-diseases/ 2024-08-23T03:29:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/singular-genomics-systems-gets-grant-for-methods-for-depleting-nucleotide-impurities-in-solutions/ 2024-08-23T03:29:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dyne-therapeutics-gets-grant-for-muscle-targeting-complexes-with-modified-oligonucleotides-for-therapy/ 2024-08-23T03:29:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/kymera-therapeutics-gets-grant-for-targeted-degradation-of-proteins-for-treating-disorders/ 2024-08-23T03:28:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/allogene-therapeutics-gets-grant-for-constitutively-active-chimeric-cytokine-receptors-for-immune-cell-enhancement/ 2024-08-23T03:28:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/praxis-precision-medicines-gets-grant-for-compounds-for-treating-sodium-channel-related-disorders/ 2024-08-23T03:28:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/wuxi-biologics-cayman-gets-grant-for-novel-anti-pd-1-antibodies-and-their-production-methods/ 2024-08-23T03:28:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/gilead-sciences-gets-grant-for-compounds-of-formula-i-for-pharmaceutical-applications/ 2024-08-23T03:27:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/merck-gets-grant-for-actrii-binding-antibodies-for-treating-various-diseases/ 2024-08-23T03:27:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/marinus-pharmaceuticals-gets-grant-for-treatment-of-tuberous-sclerosis-related-epilepsy-using-ganaxolone-2/ 2024-08-23T03:26:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ucb-gets-grant-for-thiophene-derivatives-for-treating-ige-related-disorders/ 2024-08-23T03:26:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lonza-group-gets-grant-for-multiparticulate-compositions-with-active-and-gelling-agents/ 2024-08-23T03:26:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/exelixis-gets-grant-for-crystalline-forms-of-c-met-inhibitor-compound-1/ 2024-08-23T03:26:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/yuhan-gets-grant-for-double-stranded-oligonucleotide-for-inhibiting-amphiregulin-expression/ 2024-08-23T03:25:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biolinerx-gets-grant-for-oncolytic-virus-compositions-for-cancer-treatment-and-immunity/ 2024-08-23T03:25:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/evotec-gets-grant-for-ophthalmic-formulation-containing-aflibercept-for-eye-disorders/ 2024-08-23T03:25:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/a-menarini-industrie-farmaceutiche-riunite-gets-grant-for-method-for-reducing-liquid-sample-volume-using-centrifugal-force/ 2024-08-23T03:25:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/novartis-gets-grant-for-pharmaceutical-container-with-nfc-antenna-for-authentication/ 2024-08-23T03:24:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/codexis-gets-grant-for-engineered-polypeptides-for-producing-phenylephrine/ 2024-08-23T03:24:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jazz-pharmaceuticals-gets-grant-for-treatment-of-epilepsy-using-cannabidivarin-cbdv-and-combinations/ 2024-08-23T03:24:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hanmi-science-gets-grant-for-peptide-for-preventing-or-treating-obesity/ 2024-08-23T03:24:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sage-therapeutics-gets-grant-for-cns-related-disorder-treatment-compounds-and-compositions/ 2024-08-23T03:23:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/regeneron-pharmaceuticals-gets-grant-for-generating-fertile-xy-female-animals-using-modified-embryonic-stem-cells/ 2024-08-23T03:23:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/valneva-gets-grant-for-vaccine-for-treating-or-preventing-borrelia-infections/ 2024-08-23T03:22:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/glenmark-pharmaceuticals-gets-grant-for-hetero-dimeric-immunoglobulins-targeting-cd3-and-cd38-antigens/ 2024-08-23T03:22:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mallinckrodt-gets-grant-for-identifying-premature-infants-for-inhaled-nitric-oxide-therapy/ 2024-08-23T03:22:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nektar-therapeutics-gets-grant-for-long-acting-il-15-receptor-agonist-for-immune-activation/ 2024-08-23T03:22:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/takeda-pharmaceutical-gets-grant-for-cancer-treatment-using-aurora-kinase-inhibitor-and-platin/ 2024-08-23T03:21:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bausch-health-gets-grant-for-ophthalmic-lens-with-spatially-modulated-optical-power-profile/ 2024-08-23T03:21:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jiangsu-hengrui-medicine-gets-grant-for-lag-3-antibody-for-inhibiting-tumor-cell-growth/ 2024-08-23T03:21:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/daiichi-sankyo-gets-grant-for-novel-peptide-targeting-active-mmp-9-protease/ 2024-08-23T03:21:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sangamo-therapeutics-gets-grant-for-nucleases-for-cftr-gene-alteration-and-model-generation/ 2024-08-23T03:20:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cytomx-therapeutics-gets-grant-for-antibody-conjugation-methods-for-selective-agent-placement/ 2024-08-23T03:20:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/omeros-gets-grant-for-masp-2-inhibitory-compounds-and-their-compositions/ 2024-08-23T03:20:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/insmed-gets-grant-for-treating-lupus-nephritis-with-specific-oxazepane-compounds/ 2024-08-23T03:20:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/abbvie-gets-grant-for-injectable-hyaluronic-acid-compositions-for-skin-improvement/ 2024-08-23T03:19:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dynavax-technologies-gets-grant-for-immune-response-stimulation-using-modified-imidazoquinoline-compounds/ 2024-08-23T03:19:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bayer-gets-grant-for-hybrid-corn-variety-ch011208-and-its-seeds/ 2024-08-23T03:19:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bristol-myers-squibb-gets-grant-for-mer-ax1-inhibitors-for-treating-cancer-and-related-disorders/ 2024-08-23T03:19:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/astrazeneca-gets-grant-for-methods-for-preventing-rsv-infection-using-monoclonal-antibodies/ 2024-08-23T03:18:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/galapagos-gets-grant-for-antibodies-for-treating-inflammatory-disorders-like-psoriasis/ 2024-08-23T03:18:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/jcr-pharmaceuticals-gets-grant-for-fusion-antibody-for-treating-iduronate-2-sulfatase-deficiency/ 2024-08-23T03:17:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/dr-reddy-s-laboratories-gets-grant-for-cancer-treatment-using-1-2-4-oxadiazole-compounds/ 2024-08-23T03:17:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/nippon-shinyaku-gets-grant-for-measuring-container-for-dispensing-tablets-2/ 2024-08-23T03:17:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/shionogi-gets-grant-for-bone-density-enhancement-using-specific-plant-extracts/ 2024-08-23T03:17:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/intra-cellular-therapies-gets-grant-for-acute-treatment-methods-for-depression-and-anxiety/ 2024-08-23T03:16:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/moderna-gets-grant-for-lnp-encapsulated-mrna-treatment-for-solid-tumors-and-lymphomas/ 2024-08-23T03:16:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/mannkind-gets-grant-for-fluid-transfer-adapter-for-medical-devices/ 2024-08-23T03:16:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/zoetis-gets-grant-for-vaccine-for-porcine-epidemic-diarrhea-virus-pedv/ 2024-08-23T03:16:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/incyte-gets-grant-for-pim-kinase-inhibitor-salt-forms-for-cancer-treatment/ 2024-08-23T03:15:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hca-healthcare-gets-grant-for-user-specific-information-display-system-for-collocated-users/ 2024-08-23T03:15:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/lipocine-gets-grant-for-oral-testosterone-undecanoate-compositions-for-replacement-therapy/ 2024-08-23T03:15:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/chiesi-farmaceutici-gets-grant-for-modified-release-tablets-containing-deferiprone-for-oral-administration/ 2024-08-23T03:15:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/xencor-gets-grant-for-il-10-fc-fusion-proteins-for-targeted-immune-modulation/ 2024-08-23T03:14:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/united-therapeutics-gets-grant-for-automated-system-for-organ-decellularization-protocol-implementation/ 2024-08-23T03:14:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ono-pharmaceutical-gets-grant-for-combined-treatment-of-tumors-using-eribulin-and-pd-1-antagonist/ 2024-08-23T03:13:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amicus-therapeutics-gets-grant-for-treatment-methods-for-fabry-disease-using-migalastat/ 2024-08-23T03:13:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biogen-gets-grant-for-anti-vla-4-antibodies-for-treating-multiple-sclerosis-and-epilepsy/ 2024-08-23T03:13:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/organovo-gets-grant-for-bioprinting-three-dimensional-biological-tissues-using-low-temperatures/ 2024-08-23T03:13:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/anges-gets-grant-for-crispr-method-for-modifying-cxcr4-gene-mutations/ 2024-08-23T03:12:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cellectis-gets-grant-for-increased-dietary-fiber-in-hexaploid-triticum-plants/ 2024-08-23T03:12:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/alnylam-pharmaceuticals-gets-grant-for-inhibiting-gnaq-expression-in-cancer-cells-using-dsrna/ 2024-08-23T03:12:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ascendis-pharma-gets-grant-for-long-acting-growth-hormone-treatment-for-deficiency-in-children/ 2024-08-23T03:12:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/eyepoint-pharmaceuticals-gets-grant-for-methods-for-treating-vascular-leak-syndrome-and-cancer/ 2024-08-23T03:11:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/santen-pharmaceutical-gets-grant-for-treatment-of-dry-eye-using-olodaterol-hydrochloride/ 2024-08-23T03:11:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ligand-pharmaceuticals-gets-grant-for-high-throughput-screening-of-variant-proteins-using-microcapillary-arrays/ 2024-08-23T03:11:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/axsome-therapeutics-gets-grant-for-combination-treatment-for-migraine-using-meloxicam-and-rizatriptan/ 2024-08-23T03:11:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/merus-gets-grant-for-novel-anti-human-pd-1-binding-domains-for-cancer-treatment/ 2024-08-23T03:10:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/inovio-pharmaceuticals-gets-grant-for-modified-consensus-mesothelin-antigen-for-cancer-treatment/ 2024-08-23T03:10:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/precision-biosciences-gets-grant-for-engineered-meganucleases-for-modifying-dystrophin-gene/ 2024-08-23T03:10:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ionis-pharmaceuticals-gets-grant-for-inhibiting-irf4-expression-to-treat-associated-cancers/ 2024-08-23T03:10:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/corcept-therapeutics-gets-grant-for-pyrimidinedione-compounds-as-glucocorticoid-receptor-modulators/ 2024-08-23T03:09:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/cara-therapeutics-gets-grant-for-oral-formulation-of-kappa-opioid-receptor-agonist-for-treatment/ 2024-08-23T03:09:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/astellas-pharma-gets-grant-for-improved-oral-formulation-of-enzalutamide-with-polyvinyl-alcohol/ 2024-08-23T03:08:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/agenus-gets-grant-for-antibodies-that-antagonize-tim-3-function-for-treatment/ 2024-08-23T03:08:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/macrogenics-gets-grant-for-antibodies-targeting-her2-neu-for-cancer-treatment/ 2024-08-23T03:08:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biocryst-pharmaceuticals-gets-grant-for-inhibitors-of-the-complement-system-for-disease-treatment-3/ 2024-08-23T03:08:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/sanofi-gets-grant-for-syringe-support-for-autoinjector-device/ 2024-08-23T03:07:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ipsen-gets-grant-for-engineered-clostridial-toxins-with-modified-amino-acids/ 2024-08-23T03:07:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/rigel-pharmaceuticals-gets-grant-for-rip1-kinase-inhibitors-for-treating-associated-diseases/ 2024-08-23T03:07:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/pfizer-gets-grant-for-antibody-drug-conjugate-targeting-cd30-for-tumor-treatment/ 2024-08-23T03:07:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/les-laboratoires-servier-gets-grant-for-anti-pd-1-antibodies-for-cancer-treatment/ 2024-08-23T03:06:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/viatris-gets-grant-for-device-for-injecting-medicament-using-a-skin-sensor/ 2024-08-23T03:06:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/johnson-johnson-gets-grant-for-discectomy-tool-with-steering-and-irrigation-features/ 2024-08-23T03:05:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vertex-pharmaceuticals-gets-grant-for-genetically-modified-cells-for-treating-hemoglobinopathies/ 2024-08-23T03:05:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/biontech-gets-grant-for-computer-implemented-method-for-designing-electrical-circuits/ 2024-08-23T03:05:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/ac-immune-gets-grant-for-liposomal-vaccine-for-amyloid-beta-associated-diseases/ 2024-08-23T03:05:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/immunocore-gets-grant-for-t-cell-receptors-for-cancer-immunotherapy-targeting-prame/ 2024-08-23T03:04:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/vaccinex-gets-grant-for-antibody-composition-targeting-semaphorin-4d-for-disease-treatment/ 2024-08-23T03:04:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amgen-gets-grant-for-method-to-prevent-lamellar-silica-in-borosilicate-glass-containers/ 2024-08-23T03:04:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/aurobindo-pharma-gets-grant-for-solid-dispersion-and-improved-process-for-naloxegol-oxalate/ 2024-08-23T03:03:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/azenta-gets-grant-for-reconfigurable-substrate-transport-apparatus-with-modular-arm-link/ 2024-08-23T03:03:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/hisamitsu-pharmaceutical-gets-grant-for-quantitative-determination-of-amphetammonium-amphetacarbamate-in-polymers/ 2024-08-23T03:04:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisais-leqembi-deemed-too-costly-for-nhs/ 2024-08-22T16:20:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lexicon-to-face-fda-adcom-for-zynquista-approval-in-diabetes-and-ckd/ 2024-11-01T14:50:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/leo-pharmas-timber-bet-falls-flat-following-phase-iii-failure/ 2024-08-22T12:13:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cti-oncology-drug-development/ 2024-08-22T10:30:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/touchlight-dbdna-zika-uk/ 2024-08-22T10:13:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/secondary-packaging-for-sterile-injectables-overcoming-todays-design-challenges/ 2025-07-03T10:35:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/innovents-china-treatment/ 2024-08-22T08:30:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-sbla-opdivo-yervoy-hcc/ 2024-08-22T08:25:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pathalys-secures-105m-to-advance-shpt-drug-through-approval/ 2024-08-21T19:10:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/enhancing-mrna-drug-development-how-to-optimise-your-suppliers-and-materials/ 2024-09-05T15:13:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-declines-to-approve-regenerons-linvoseltamab-amid-manufacturing-issues/ 2024-08-21T16:10:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emergent-biosolutions-finalises-manufacturing-site-sale-to-bora-pharmaceuticals/ 2024-08-21T15:10:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/a-guide-to-host-cell-protein-analysis-services-for-biomanufacturers/ 2024-08-21T14:57:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aadi-axes-80-of-staff-after-registrational-phase-ii-trial-fails/ 2024-08-21T14:40:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/licensing-agreements-for-innovator-glp1r-drugs-weigh-in-with-over-6-2bn-in-2024/ 2024-09-02T10:07:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/how-personalised-medicine-revolutionise-contraception/ 2024-08-21T12:50:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dr-reddys-aurigene-kainomyx-malaria/ 2024-08-21T10:12:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-astrazeneca-fasenra-asthma/ 2024-08-21T10:06:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgens-otezla-plaque-psoriasis/ 2024-08-21T08:18:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/organon-lilly-migraine-treatment/ 2024-08-21T13:42:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/adcendo-and-multitude-ink-adc-deal-potentially-worth-1bn/ 2024-08-20T17:28:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jjs-rybrevant-plus-lazcluze-combination-gets-fda-approval-in-nsclc/ 2024-08-20T17:14:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/realta-bags-fda-orphan-drug-and-fast-track-designations-for-gvhd-therapy/ 2024-08-20T16:28:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emergent-joins-mpox-fight-with-50000-vaccine-dose-donation-to-africa/ 2024-08-20T23:02:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/top-20-biopharma-market-cap-up-q2-2024/ 2024-08-20T15:14:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/glp-1r-market-two-horse-race/ 2024-08-20T11:21:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/accenture-earli-cancer-detection/ 2024-08-20T10:27:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/liquidias-yutrepia-powder-fda/ 2024-08-20T10:23:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/colombia-president-signs-law-to-strengthen-pharmaceutical-sector/ 2024-08-20T09:36:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nmpa-astellas-padcev-cancer/ 2024-08-20T08:29:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-abbvie-tepkinly-lymphoma/ 2024-08-20T08:21:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sound-pharmaceuticals-plans-to-stick-with-wuxi-amids-biosecure-act-rumblings/ 2024-08-22T11:53:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/south-african-president-calls-on-who-for-better-mpox-response/ 2024-08-19T16:10:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deepcure-links-with-leeds-institute-to-bring-ai-based-ra-drug-to-clinic/ 2024-08-19T16:09:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-dod-grants-2-3m-to-immuron-for-military-version-of-anti-diarrhoeal-travelan/ 2024-08-19T14:36:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/phanes-acquires-second-fda-orphan-designation-for-bispecific-antibody/ 2024-08-19T13:35:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/overcoming-common-challenges-in-fill-finish-for-monoclonal-antibodies-mabs/ 2025-07-03T10:10:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/scisparc-license-deal-polyrizon/ 2024-08-19T10:24:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-astrazeneca-enhertu/ 2024-08-19T10:19:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-partners-pantherx/ 2024-08-19T09:11:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-concludes-morphic-acquisition/ 2024-08-19T09:08:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-and-biontechs-covid-19-flu-combination-vaccine-falters-in-phase-iii-readout/ 2024-08-20T12:29:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-wins-approval-for-imfinzi-in-nsclc-perioperative-setting/ 2024-08-16T15:06:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bavarian-nordic-seeks-authorisation-for-mpox-vaccines-use-in-adolescents/ 2024-08-16T14:43:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/armed-with-phase-iii-win-incyte-eyes-label-expansion-for-monjuvi/ 2024-08-16T13:48:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lykos-cuts-workforce-mdma-rejection-fda/ 2024-08-16T10:29:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hoth-aronnax-cancer-therapy/ 2024-08-16T10:20:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-deciphera-vimseltinib-nda/ 2024-08-16T10:16:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-genomic-medicine-revolution-multi-modality-approaches-in-advanced-therapies/ 2024-08-16T12:12:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nuntius-partners-taiho-to-develop-mrna-cancer-therapies/ 2024-08-20T06:18:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazenecas-sbla-imfinzi-gains-fda-priority-review/ 2024-08-16T08:27:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/clinical-research-in-the-uk-must-build-on-industry-collaboration-says-nihr-director/ 2024-09-26T21:10:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gileads-pbc-therapy-livdelzi-bags-accelerated-approval/ 2024-08-15T16:55:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-government-unveils-finalised-drug-prices-under-inflation-reduction-act/ 2024-08-16T08:47:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/evotec-slashes-workforce-by-400-people-in-difficult-market/ 2024-08-15T16:16:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-greenlights-incyte-and-syndaxs-gvhd-drug-niktimvo/ 2024-08-15T15:44:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-clinical-trials-can-use-ai-responsibly-and-effectively/ 2024-08-15T15:29:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/arrowhead-announces-push-into-obesity-space-with-two-gene-therapies/ 2024-08-15T14:43:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/replimune-announces-first-patient-dosed-in-trial-studying-rp1-against-melanoma/ 2024-08-14T20:31:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kezar-stalls-solid-tumour-trial-to-focus-on-autoimmune-disease-candidate/ 2024-08-14T14:56:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bavarian-nordic-outlays-215000-mpox-vaccine-dose-supply-to-african-countries/ 2024-08-14T14:35:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/acelyrin-deprioritises-lead-therapy-despite-phase-iii-win-fires-33-of-staff/ 2024-08-14T12:45:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/diabesity-overlapping-pathophysiology-informs-multi-indication-treatment/ 2024-08-14T11:11:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/northstar-convergent-expand-deal/ 2024-08-14T10:07:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bioarctic-eisai-leqembi-uae/ 2024-08-14T10:04:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-gastric-cancer-therapy-china/ 2024-08-14T08:10:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-inaugurates-new-facility/ 2024-08-14T08:03:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-judge-denies-initial-attempt-by-novartis-to-block-generic-entresto-launch/ 2024-08-13T16:10:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/glp-1-receptor-agonists-cut-risk-of-death-in-inflammatory-disease-patients-says-study/ 2024-08-13T16:06:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-government-announces-plan-to-reduce-healthcare-red-tape/ 2024-08-13T15:37:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/madrigal-rezdiffra-mash/ 2024-08-13T15:19:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/baxter-signs-over-kidney-care-arm-to-investment-firm-in-3-5bn-deal/ 2024-08-13T15:24:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/syros-stock-craters-after-phase-ii-aml-trial-termination-due-to-inefficacy/ 2024-08-13T13:05:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/safety-first-cognition-as-a-primary-safety-endpoint-provides-a-competitive-advantage/ 2024-08-13T12:53:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astria-therapeutics-taps-ypsomed-autoinjector-for-hereditary-angioedema-drug-delivery/ 2024-08-13T13:15:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-junshi-melanoma-toripalimab/ 2024-08-13T10:11:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-galderma-prurigo-nodularis/ 2024-08-13T10:04:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/citius-oncology-tenx-keane/ 2024-08-13T08:28:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ascendis-yorvipath-fda-approval/ 2024-08-13T08:24:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-sandozs-enzeevu-as-eylea-biosimilar-saga-continues/ 2024-08-13T16:13:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-touts-positive-topline-data-for-rsv-vaccine-abrysvo/ 2024-08-12T15:50:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/patient-with-rare-neurodegenerative-disorder-improves-with-non-profits-aso-therapy/ 2024-08-12T15:24:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/leap-consulting-launches-practice-to-assist-labs-with-fda-ldt-ruling/ 2024-08-12T13:02:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-rejects-lykos-mdma-therapy-asks-for-another-phase-iii-trial/ 2024-08-12T12:16:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-iaso-bios-ind/ 2024-08-12T13:16:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/blue-earth-radiopharmaceutical-seibersdorf/ 2024-08-12T13:19:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/era-of-adcs-pharma-companies-innovate-to-stand-out-in-a-buzzing-market/ 2024-10-30T09:59:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sable-columbia-obesity-treatments/ 2024-08-12T08:26:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ars-pharmaceuticals-anaphylaxis-nasal-spray/ 2024-08-12T08:20:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-sets-sights-on-bispecific-antibody-market-with-curon-acqusition/ 2024-08-09T19:21:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-support-theramexs-eladynos-for-post-menopause-osteoporosis/ 2024-08-09T14:36:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-boosts-sales-forecast-by-3bn-as-diabetes-and-weight-loss-drugs-propel-revenue/ 2024-08-09T14:11:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/an2-slashes-staff-by-50-after-lead-antibiotic-flunks-in-phase-ii-iii-trial/ 2024-08-09T13:26:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/adaptimmune-soft-tissue-sarcoma-therapy/ 2024-08-09T11:02:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-net-income-q2-2024/ 2024-08-09T10:34:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/wuxi-medigene-t-cell-cancer/ 2024-08-09T10:31:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-the-glp-1-receptor-agonist-market-could-hit-168bn-by-2033/ 2024-08-09T12:58:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/momentum-biotechnologies-cube-biotech/ 2024-08-09T08:23:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/recursion-exscientia-merger/ 2024-08-09T08:17:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/crispr-based-casgevy-is-made-accessible-in-england-following-nice-guidance/ 2024-08-08T17:34:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/conduit-acquires-three-first-in-class-assets-from-astrazeneca/ 2024-08-08T16:32:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharmacosmos-ventures-into-oncology-and-merges-with-g1-therapeutics/ 2024-08-08T16:14:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/purdue-receives-clearance-for-opioid-overdose-injector-for-younger-individuals/ 2024-08-08T13:45:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bavarian-nordic-tops-up-us-smallpox-mpox-vaccine-stockpile-with-156-8m-order/ 2024-08-08T13:41:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takedas-adzynma-eu-cttp/ 2024-08-08T10:27:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amneals-crexont-fda-parkinsons/ 2024-08-09T03:54:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsks-jemperli-endometrial-cancer-singapore/ 2024-08-09T03:41:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-novartis-fabhalta-igan/ 2024-08-08T08:25:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/addressing-industry-challenges-through-flexible-personalized-ecoa-solutions/ 2024-08-07T19:19:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hepatitis-b-market-is-ripe-for-treatment-development-says-aligos-ceo/ 2024-08-07T16:33:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/idrx-raises-120m-to-fund-gastric-tumour-trials-for-lead-tki-therapy/ 2024-08-07T15:40:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisks-wegovy-sales-weaken-as-eli-lillys-zepbound-exerts-pressure/ 2024-08-07T15:13:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/precigen-cuts-workforce-by-20-to-focus-on-gene-therapy-for-benign-tumours/ 2024-08-07T14:21:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-net-income-q2-2024/ 2024-08-07T10:15:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-servier-voranigo/ 2024-08-07T10:09:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genentech-sangamo-neurodegenerative-diseases/ 2024-08-07T08:22:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-msd-expand-collaboration/ 2024-08-12T13:09:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/dashboards/deals-dashboards/privateequity-activity-electronic-medical-record-emr-systems-pharmaceutical-industry/ 2024-08-07T02:41:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chime-looks-to-expand-manufacturing-capacity-and-establish-european-presence/ 2024-08-07T07:56:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/concentric-analgesics-highlights-data-on-vocacapsaicin-for-pain-relief/ 2024-08-06T15:56:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-casts-a-wide-net-to-hook-opportunities-in-metabolic-disorders/ 2024-08-06T15:02:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/developing-high-potent-apis-the-necessary-steps-to-follow/ 2026-02-13T12:25:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/global-stock-market-crash-likely-to-delay-biotech-ipos/ 2024-08-06T13:22:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-saas-platforms-are-breaking-the-mold-for-clinical-trials/ 2025-05-27T16:30:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/crznomics-gene-therapies/ 2024-08-06T10:40:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-rpdd-meta-hyperoxaluria/ 2024-08-07T03:43:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/malaysia-approves-antengenes-xpovio/ 2024-08-06T08:38:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-zantac-cancer-lawsuit/ 2024-08-06T08:30:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mallinckrodt-sells-therakos-to-cvc-capital-partners-for-925m/ 2024-08-05T15:44:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biontech-exits-pd-l1-development-with-genmab-as-q2-revenues-drop/ 2024-08-05T15:35:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zevra-wins-fda-panel-backing-for-previously-rejected-arimoclomol/ 2024-08-05T15:07:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bayer-set-to-expand-kerendias-label-in-cardiology-with-phase-iii-win/ 2024-08-05T13:09:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/formosa-apotex-licencing-deal/ 2024-08-05T10:51:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-sfj-serb-bentracimab/ 2024-08-05T10:26:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/whats-involved-in-designing-effective-lyophilization-cycles/ 2025-07-03T10:09:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ec-amylyx-wolfram-syndrome/ 2024-08-05T08:24:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/anivive-valley-fever-vaccine/ 2024-08-05T08:19:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vir-bio-trims-staff-and-pipeline-to-focus-on-sanofi-licensed-programmes/ 2024-08-02T15:41:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/adaptimmunes-tecelra-gains-accelerated-approval-for-synovial-sarcoma/ 2024-08-02T15:34:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/casgevy-launch-crispr-therapy/ 2024-08-02T14:03:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cellectis-starts-alemtuzumab-revival-with-fda-orphan-drug-win-in-leukaemia/ 2024-08-02T13:39:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rejuvenate-and-sas-partner-to-harness-ai-for-age-related-diseases/ 2024-08-02T10:45:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-insulin-production-germany/ 2024-08-02T10:30:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsks-jemperli-fda-approval/ 2024-08-02T10:24:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-acquires-mirus-bio/ 2024-08-02T08:32:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-cerevel-therapeutics/ 2024-08-02T08:26:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aaic-2024-eisai-presents-positive-long-term-data-with-leqembi/ 2024-08-01T16:40:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aaic-2024-mci-patient-reflects-on-leqembi-trial-experience/ 2024-08-01T16:11:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hillevax-slashes-workforce-by-40-after-norovirus-vaccine-trial-failure/ 2024-08-01T15:39:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/otsuka-snaps-up-jnana-with-its-phenylketonuria-drug-for-800m/ 2024-08-01T15:28:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/valneva-and-limmatech-partner-for-shigellosis-vaccine-development/ 2024-08-01T15:26:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/chronic-lymphocytic-leukaemia-the-global-clinical-trials-landscape-in-2024/ 2024-08-07T11:41:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/understanding-ich-guideline-q14/ 2024-08-06T12:13:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/molecure-avicenna-cancer-treatment/ 2024-08-01T10:25:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abcellera-lilly-deal-antibodies/ 2024-08-01T10:20:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-revenue-q1-fy2024/ 2024-08-01T08:46:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nice-beigene-mzl-tablet/ 2024-08-01T08:06:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bayer-in-ecommerce-theme-innovation-strategy/ 2024-08-01T06:12:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/bayer-in-batteries-theme-innovation-strategy/ 2024-08-01T06:12:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amgen-in-internet-of-things-theme-innovation-strategy/ 2024-08-01T06:11:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/data-insights/amgen-in-mobile-theme-innovation-strategy/ 2024-08-01T06:11:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-left-in-limbo-when-pharma-halts-rare-disease-research/ 2024-07-31T16:10:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fibrogen-axes-75-of-staff-after-lead-cancer-therapy-fails-in-phase-iii-trials/ 2024-07-31T15:44:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/imunons-shares-soar-after-il-12-therapy-success-in-phase-ii-trial/ 2024-07-31T15:49:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vertexs-blockbuster-in-waiting-painkiller-suzetrigine-set-for-fda-review-next-year/ 2024-07-31T15:37:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/revenue-growth-biopharmas-obesity-drug-successes-2023/ 2024-07-31T13:40:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/novo-growth-challenges-obesity-boom/ 2024-07-31T12:50:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-cost-revealed-2025-application-drug/ 2024-07-31T11:02:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/leveragen-moderna-advance-therapeutics/ 2024-07-31T10:13:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-net-income-q2-2024/ 2024-07-31T10:06:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-net-income-q2-2024/ 2024-07-31T08:15:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-johnson-johnson-multiple-myeloma/ 2024-07-31T08:10:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biotech-ipo-q1-2024/ 2024-08-05T12:35:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ventyx-scraps-tyk2-inhibitor-after-phase-ii-crohns-defeat/ 2024-07-30T20:54:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/study-finds-semaglutide-decreases-tobacco-related-healthcare/ 2024-07-30T16:15:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roches-vabysmo-challenges-eylea-dominance-with-third-european-indication/ 2024-07-30T13:47:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/collegium-buys-ironshore-for-525m-and-enter-adhd-market/ 2024-07-30T13:18:54+00:00 daily 0.2